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 Gemini surfactants are an intriguing class of surface active agents that are comprised of 
two surfactant monomers chemically linked at or near the headgroups by a rigid or flexible 
spacer. In comparison to their corresponding monomer counterparts, gemini surfactants are more 
efficient at reducing surface tension, have better wetting properties, and typically have critical 
micelle concentration values that are one to two orders of magnitude lower. These intriguing 
properties characteristic of gemini surfactants make them of special interest for pharmaceutical 
applications. 
 Within this work, two different projects were carried out to assess the pharmaceutical 
applications of gemini surfactants. The aim of the first project was to assess the applications of 
gemini surfactants as transfection agents for non-viral gene delivery by evaluating the physical 
stability characteristics of gemini surfactant-based lipoplex systems. Prior to this investigation, 
an evaluation of the interaction properties between gemini surfactants and DNA, and between 
gemini surfactants and the neutral helper lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine 
was carried out using a combination of isothermal titration calorimetry, particle size, zeta 
potential and surface tension measurements. Following these evaluations, the physical stability 
of the gemini surfactant-based DNA delivery systems was assessed by examining the particle 
size distribution and membrane integrity characteristics of the lipoplexes. The results from this 
analysis revealed that the physical stability of these systems is limited by the membrane integrity 
characteristics of the lipoplex structure. 
 The second project carried out was an evaluation of the interactions between gemini 
surfactants and a series of Tween surfactants commonly found in pharmaceutical formulations. 
The results from this analysis were analyzed using Clint’s, Rubingh’s, Motomura’s and Maeda’s 
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theories for mixed micelle formation, where it was observed that there is a general synergistic 
mixing interaction present between gemini and Tween surfactants. The strength of synergism 
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1.1 Introduction to Gemini Surfactants  
 Gemini surfactants represent an intriguing class of surface active agents that have been 
extensively studied by various research groups since the late 1980s. Their unique structure, 
which consists of two typical surfactant monomers that are covalently linked by either a rigid or 
flexible spacer group (see scheme 1.1), results in a number of interesting observations regarding 
their properties in aqueous solution.1 In comparison to their corresponding monomer 
counterparts, gemini surfactants are more efficient at reducing surface tension, have better 
wetting properties, and typically have critical micelle concentration (CMC) values that are one to 
two orders of magnitude lower.1-3 Furthermore, gemini surfactants have been shown to form a 
rich array of aggregate morphologies in solution, through alteration of their chemical structure.4,5 
The combination of the unique properties of these surfactants along with the increasing demand 
for high performance surfactants is currently driving research into their potential applications. 
 
Typical Surfactant    Gemini Surfactant 
    Polar Headgroup                                                    
                                                                    
                 Spacer Group 




Scheme 1.1 Comparison of the structure of a typical surfactant with a gemini surfactant. 
  
 The prospective applications of gemini surfactants are multi-fold. These include their 
potential use in cleaning agents and detergents; cosmetics and personal care products; 
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preparative chemistry; pharmaceutical and biological applications; enhanced oil recovery etc.6 
One particular application that is currently heavily investigated, in particular by the Wettig 
research group, is the use of gemini surfactants in drug delivery.  
 The overall aim of this thesis is to provide an evaluation of the pharmaceutical 
applications of gemini surfactants. This was carried out in a series of projects which, i) evaluated 
the applications of gemini surfactants as transfection agents for non-viral DNA delivery, and ii) 
investigated the interactions of gemini surfactants with a series of Tween surfactants commonly 
found in pharmaceutical formulations. The details and rational of these two objectives are 
discussed below in sections 1.2 and 1.3, respectively. 
 
1.2 Gemini Surfactants as Transfection Agents for Non-Viral Gene Therapy 
1.2.1 Introduction to Gene Therapy 
 Gene therapy represents an intriguing therapeutic strategy for the treatment of both 
genetic and acquired diseases.7 The main objective behind this technology is to insert genetic 
material into a patient’s cells to help correct defective genes that may be responsible for disease 
development.7 Through intervention at the genetic level, specific cellular functions can be 
restored, modified or enhanced.7 As of June 2010, there are 1644 ongoing gene therapy clinical 
trials worldwide, where the majority of trials are oriented towards the treatment of cancer (1060), 
cardiovascular (143), monogenic (134) and infectious diseases (131).8 The major gene types 
utilized in these trials include antigen (325), cytokine (302) and tumor suppressor (173) 
strategies.8  
 Currently, the most efficient method to deliver DNA into the cell nucleus is through the 
incorporation of therapeutic DNA into engineered viruses.9,10 This method, entitled viral gene 
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therapy, has been found to show promising transfection results as this vector enables the 
integrated DNA to efficiently cross various physiological barriers upon administration.11 As a 
result, the incorporated DNA can effectively be introduced into the cell nucleus and ultimately 
expressed.11 
 In light of the high transfection efficiencies characteristic to viral vectors, there are 
however various concerns that hinder their practicality as a suitable system for DNA delivery.12 
Viral delivery systems generally present safety and toxicity concerns as they can trigger severe 
immune responses, which have been observed in several human and animal clinical trials.13 This 
was severely demonstrated during a gene therapy clinical trial conducted at the University of 
Pennsylvania in 1999, which resulted in the death of Jesse Gelsinger who received treatment 
from an adenoviral vector to correct partial ornithine transcarbamylase deficiency; Gelsinger’s 
death was a result of multiple organ failure due to an immune response to the adenoviral 
vector.12 Another setback was experienced in 2002, when two patients participating in a clinical 
trial for the treatment of severe combined immunodeficiency developed leukemia, which 
appeared to be linked to the activation of an oncogene adjacent to the site of vector insertion.14 
These two examples, among others, clearly exemplify the safety concerns associated with viral 
strategies. Viral vectors additionally suffer from the disadvantages of having limitations with 
respect to the size of the plasmid that can be incorporated,15 long-term storage concerns, and 
difficult preparation and purification procedures.16 As a result, there has been a shift into the 
research and development of non-viral vectors, which have been shown to counteract many of 
these disadvantages. 
 Non-viral gene therapy approaches offer numerous advantages in comparison to 
conventional viral vectors for several reasons. Most significantly, non-viral vectors are generally 
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non-toxic and non-immunogenic.17 They additionally provide the advantages of being relatively 
cheap and easy to produce, and are not limited (from a practical standpoint) in the size of the 
plasmid that can be incorporated.17,18 As well, they allow for specialized delivery options such as 
targeted delivery, time-dependent release, and enhanced circulation times.17,18 Despite these 
numerous advantages, it is important to note that non-viral vectors suffer from low transfection 
efficiencies in vivo, as compared to viral based systems.16 
 Non-viral approaches range from a variety of different physical (direct needle injection of 
naked DNA, gene gun, electroporation etc.) and chemical (cationic lipids, surfactants, polymers 
etc.) gene transfer methods.19 Since the first description of successful in vitro transfection using 
cationic lipids in 1987,20 lipofection is regarded as one of the more popular studied strategies for 
non-viral gene delivery. Lipofection essentially involves the use of cationic lipids to form 
liposome/DNA complexes (termed a “lipoplex”), which can be utilized as a delivery vector for 
therapeutic DNA.19 As of June 2010, there are 109 ongoing clinical trials worldwide utilizing 
lipofection-based strategies.8   
 
1.2.2 Gemini Surfactants as Transfection Agents for Non-Viral Gene Therapy 
 As previously introduced, one of the potential applications of gemini surfactants is their 
use as transfection agents for non-viral gene delivery. More specifically, gemini surfactants can 
be used as building blocks for the construction of liposome/DNA complexes. The unique 
structural and solution properties of gemini surfactants make them intriguing candidates for use 
in such systems for a variety of reasons. For one, their multi-cationic nature allows for the 
effective binding and thus compaction of DNA.21 In addition, gemini surfactants can be 
synthesized fairly easily and at low cost, therefore making them advantageous from a 
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pharmaceutical industrial manufacturing and economical perspective. As well, their unique 
solution properties allow them to readily associate in aqueous environments, thus making them 
efficient at low concentrations which subsequently reduces their concentration requirements 
during complex formation. This is advantageous from a toxicity perspective, where the first and 
simplest step to optimize the safety profile of any foreign complex is to reduce its concentration 
in vivo.  
 Overall, gemini surfactants are viewed as effective potential transfection agents for non-
viral gene therapy. In vitro experiments have shown that gemini surfactant-based lipoplex 
systems are capable of providing comparable transfection efficiencies to commercially available 
transfection agents, one example of which is Lipofectamine Plus (Invitrogen).16 Despite these 
positive results, further work is still needed to 
 
 i) improve the transfection efficiencies of these delivery systems, ideally to comparable 
 levels of their viral counterparts 
 ii) assess the stability properties of these lipoplexes.  
 
 An evaluation of the physical stability of gemini surfactant-based DNA delivery systems 
will form the basis of the first objective of this thesis. 
 
1.2.3 Stability of Gemini Surfactant-based Lipoplexes 
 In the literature, the majority of studies on lipoplex delivery systems have focused on 
characterizing and improving their transfection efficiencies, while evaluations on their stability 
characteristics has received little attention.22 As will be discussed in more detail in Chapter 2.3, 
the stability properties of these systems is of great importance because they carry significant 
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implications with respect to the safety and efficacy characteristics of the lipoplex within the 
human body. If these lipoplex delivery systems are found to be relatively unstable during 
storage, their pharmaceutical applications become limited in that they must be prepared prior to 
administration, by specifically trained individuals. Without argument, it can be stated that the 
stability characteristics of non-viral vectors is of great significance when assessing their overall 
viable potential towards gene therapy applications. 
 In order to effectively evaluate the stability properties of gemini surfactant-based DNA 
delivery systems, an overall understanding of the physicochemical properties of the lipoplex 
structure is crucial. This requires an understanding of the main interactions involved between the 
components of these systems, which are composed of the gemini surfactant, the plasmid DNA, 
and the neutral helper lipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). The helper 
lipid DOPE is included in the formulation to provide flexibility to the lipoplex structure, so that 
multiple conformations can be adopted.16,23 This ability to adopt multiple conformations is 
believed to aid in membrane fusion and destabilization of the endosomal membrane, thus 
enhancing the entry of the incorporated DNA into the cell.23 Previously reported results have 
shown that the inclusion of DOPE in gemini surfactant-based lipoplexes significantly increases 
the transfection efficiency.16  
 The two main interactions within gemini surfactant-based lipoplex systems that are of 
great significance and interest are, i) the interaction between gemini surfactants and DNA, and ii) 
the interaction between gemini surfactants and DOPE. The interaction between gemini 
surfactants and DNA is of great importance because the main driving force of complexation 
between the liposome structure and DNA is from an electrostatic interaction between the cationic 
gemini headgroups and the negatively charged DNA backbone. The interaction between gemini 
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surfactants and DOPE is of importance because the liposome structure is a mixed aggregate of 
these two components; therefore the overall properties of the liposome structure are dependent 
on the mixing behaviour of gemini surfactants and DOPE. Ultimately, a better understanding of 
these two key interactions will lay the foundation for an understanding and rationalization of the 
physical stability characteristics of gemini surfactant-based DNA delivery systems. 
 As a whole, the first objective of this thesis is to perform a preliminary evaluation of the 
physical stability characteristics of gemini surfactant-based DNA delivery systems. Prior to this 
evaluation, an investigation of the interactions between gemini surfactants and DNA, and 
between gemini surfactants and DOPE will be carried out.   
 
1.3 Interactions of Gemini Surfactants with Pharmaceutical Surfactants 
 As already touched upon, gemini surfactants offer numerous advantages which make 
them intriguing candidates for use in pharmaceutical formulations. These advantages include 
their high efficiencies in reducing surface tension, low CMC values, superior wetting properties, 
and their ease and low cost of synthesis.1-3 In order to further effectively assess the 
pharmaceutical applications of gemini surfactants towards drug delivery, an understanding of the 
interactions between gemini surfactants and other surfactants commonly found in pharmaceutical 
formulations is essential. This is of importance because pharmaceutical preparations normally 
contain mixtures of surface active compounds to provide the overall performance required for a 
particular application. In such instances, it is important to be aware that there can be substantial 
differences in the micellization tendencies of mixtures of surfactants, as compared to the single 
pure species.24  
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 Mixtures of surface active agents form mixed micellar aggregates in aqueous solution, 
but the tendency towards aggregation can be different than that of the individual surfactants.24 In 
ideal situations, there is no net-interaction between the amphiphile components, and the CMC of 
the mixed aggregate can be predicted using Clint’s model, which relates the CMC of the mixed 
aggregate to the CMCs of the individual surfactants and the solution composition (note that 
Clint’s equation will be discussed in more detail in Chapter 2.2).25 Clint’s ideal solution theory is 
an effective method for explaining the mixing behaviour of surfactants with chemically similar 
structures.24 However, deviations in ideal mixing can occur in mixtures containing chemically 
distinct structures as a result of a net interaction between the amphiphiles.24 This net interaction 
can be attractive or repulsive in nature, and can occur as a result of, i) electrostatic interactions 
between ionic groups, ii) ion-dipole interactions between ionic and nonionic groups, iii) steric 
interactions between bulky groups, iv) van der Waals interactions between hydrophobic groups, 
and v) hydrogen bonding between the constituent surfactant molecules.26  
 In systems exhibiting non-ideal mixing, the nature and strength of the net interaction 
between the amphiphiles can be assessed by determining the interaction parameter, β, which can 
be calculated using Rubingh’s model for mixed micellar formation (discussed in more detail in 
Chapter 2.2).24 Negative values of β indicate a synergistic/attractive mixing interaction between 
the amphiphiles, where the CMC of the mixed aggregate is lower than the ideal CMC value.24 In 
contrast, positive values of β represent an antagonistic/repulsive interaction between the 
amphiphiles, where the CMC of the mixed aggregate is larger than the ideal CMC value.24 
Synergistic mixing interactions are typically moderately present in mixtures of ionic and 
nonionic surfactants,27-29 and are relatively strong in mixtures of anionic and cationic 
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surfactants.30 Antagonistic interactions have been observed between surfactants with similar 
headgroups but different chain structures.31  
 In pharmaceutical preparations, the use of surfactant mixtures which exhibit synergistic 
mixing interactions are beneficial due to their enhanced interfacial properties over the individual 
surfactants in the mixture. As a result of these enhanced interfacial properties (i.e. greater surface 
activities and lower CMCs), surfactant concentration requirements during formulation are 
reduced, which subsequently reduces cost and environment impact. In the literature, the 
interactions between gemini surfactants and conventional surfactants have been well documented 
and in most instances, mixtures of gemini surfactants and conventional cationic, anionic or 
nonionic surfactants have been found to exhibit synergistic mixing interactions.32 To our 
knowledge, the interactions between gemini surfactants and pharmaceutical Tween surfactants 
has not been reported; an investigation of this interaction will form the basis of the last project in 
this thesis. The Tween surfactants are perhaps the most widely used surfactants in 
pharmaceutical formulations, in large part due to their nontoxic nature and approval as food 
grade surfactants.33 In addition, Tween surfactants are commonly used in pharmaceutical 
dispersions because of their effectiveness at solubilisation, wetting, and reducing surface or 
interfacial tension.34 As a result, they are widely used in the preparation of creams, emulsions 
and ointments for topical applications; as solubilising agents for a variety of substances, such as 
essential oils and oil-soluble vitamins; and as wetting agents in the preparation of oral and 
parental suspensions.34  
 As a whole, the second objective of this thesis is to investigate the mixing interactions 
between gemini surfactants and pharmaceutical Tween surfactants. This investigation will be 
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carried out using Clint’s, Rubingh’s, Motomura’s and Maeda’s theories of mixed micelle 
formation. These particular theories will be discussed in more detail in Chapter 3 of this thesis. 
 
1.4 Thesis Objectives 
 In summary, this thesis involves two separate objectives, which can be broken down into 
four projects. The first main objective is to evaluate the physical stability characteristics of 
gemini surfactant-based DNA delivery systems. Prior to this analysis, the interactions between 
gemini surfactants and DNA, and between gemini surfactants and DOPE will be investigated.  
 The second objective of this thesis is to investigate the interaction properties between 
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 Within this study, the interaction properties between gemini surfactants and DNA was 
investigated. As introduced in Chapter 1, the interaction between these two components is of 
great importance because complexation between the gemini/DOPE liposome and DNA is driven 
primarily by the electrostatic interactions between the cationic gemini headgroups and the 
negatively charged DNA molecules.  
 In the literature, properties such as the structure, morphology and thermodynamics of 
cationic surfactant/DNA complexes have been previously investigated using a variety of 
methods.1-10 These studies have shown that variations in the length, degree of unsaturation, and 
chemical structure of the surfactant alkyl chain; along with the headgroup structure and nature of 
the counterion can each exhibit a significant effect on the interaction properties with DNA, and 
consequently the transfection efficiency.1-10 Furthermore, the ratio of the cationic surfactant to 
DNA has been found to have a large effect on the lipoplex structural organization, and the 
transfection efficiency.4-10 However, despite such studies, there still remain questions about the 
thermodynamical properties and the mechanism of association of cationic surfactants with DNA. 
 The thermodynamics and mechanism of association of cationic amphiphiles to DNA is 
known to be complex, and mediated by a variety of physical interactions. These include ionic 
interactions between the negatively charged DNA phosphate groups and the positively charged 
amphiphile headgroups; nonpolar interactions between the DNA and amphiphile molecules; 
repulsive interactions between DNA molecules and between amphiphile headgroups; and from 
hydration effects.11,12 These forces, coupled with the individual structural properties of the 
plasmid DNA and cationic amphiphile, and the ratio of these two components, can lead to the 
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formation of a wide variety of supramolecular structures.11,12 Furthermore, since the structures 
and solution properties of DNA and cationic amphiphiles are very different, one can expect that 
the properties of complexation between DNA and the amphiphile could differ depending upon 
the order in which the components are mixed. 
 The overall aim of this investigation was to evaluate the mechanism and thermodynamic 
properties of gemini surfactant/DNA complex formation. This was carried out in the forward 
(gemini surfactant into DNA) and in the reverse (DNA into gemini surfactant) titration manner. 
The energetics of complexation were assessed using isothermal titration calorimetry (ITC); while 
particle size and zeta potential measurements were carried out to give an insight into the 
structural properties of complex formation. Surface tension measurements were employed to 
evaluate complexation from a surface perspective. Overall, the combined results from this 
analysis were used to provide a better understanding of complex formation between gemini 
surfactants and DNA. 
 2.1.2 Experimental Procedures 
 2.1.2.1 Materials 
 Two classes of gemini surfactants were employed in this study, referred to as 
nonsubstituted and amine-substituted. The nonsubstituted gemini surfactants used were of the 
N,N-bis(dimethylalkyl)-α,ω-alkanediammonium dibromide type, which can be represented by 
the notation m-s-m, where m refers to the length of the alkyl tail and s refers to the number of 



















Scheme 2.1.2.1         Representation of the general structure of the m-s-m type gemini surfactant. 
  
 The amine-substituted gemini surfactants used in this study were of the 1,9-bis(dialkyl)-
1,1,9,9-tetramethyl-5-imino-1,9-nonanediammonium dibromide type. These surfactants can be 
represented by the notation m-7NH-m; a representation of the chemical structure is illustrated 
below in Scheme 2.1.2.2. As shown, these surfactants incorporate a secondary amine group in 
the spacer. Gemini surfactant-based DNA delivery systems formulated with 12-7NH-12 have 
demonstrated a 9-fold increase in transfection efficiency, in comparison to nonsubstituted gemini 
surfactants.3 It is postulated that the presence of this pH active amine group has the potential to 
enhance the electrostatic interactions with the phosphate groups on the DNA backbone 
(particularly in a pH dependent fashion), as well as to facilitate the DNA escape from the 














Scheme 2.1.2.2 Representation of the m-7NH-m type gemini surfactants. 
 
  
 For this investigation, the 12-3-12, 12-7-12, 12-7NH-12, 16-3-16, 16-7-6 and 16-7NH-16 
gemini surfactants were used. The gemini surfactants were synthesized according to procedures 
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previously reported in the literature.3,13 Briefly, the nonsubstituted gemini surfactants were 
synthesized by reflux of the appropriate α,ω-dibromoalkane with 2 molar equivalents (plus 10% 
excess) of the appropriate N,N-dimethylalkylamine in HPLC-grade acetone for 48 hours. The 
amine-substituted gemini surfactants were synthesized by reflux of 3,3’-iminobis(N,N-
dimethylpropylamine) with 2 molar equivalents (plus 10% excess) of the appropriate 1-
bromoalkane in HPLC-grate acetonitrile for 24 hours. The crude products were recovered by 
filtration and then purified by recrystallization; the structures were confirmed using 1H NMR 
spectroscopy (Bruker 300 MHz). The surfactant purity was confirmed by the absence of a 
minimum in the post micelle region of the surface tension versus log concentration plot. 
  
Scheme 2.1.2.3   Synthesis schemes for the A) nonsubstituted m-s-m type gemini surfactants,  










































 DNA solutions were prepared using double-stranded salmon sperm DNA obtained from 
Sigma, which was used as received. DNA stock solutions were prepared by sonication, and the 
concentration was calibrated spectrophotometrically using a Thermo Scientific NanoDrop 2000 
spectrophotometer. 
 Water for all solutions was obtained from a Millipore Synergy purification system. 
 2.1.2.2 Methods 
 ITC measurements were performed using a MicroCal VP-ITC calorimeter. Aliquots 
(usually 5μL) of salmon DNA solution were injected from a Hamilton syringe into the sample 
cell containing the desired gemini surfactant; water was used as a reference. The experimental 
temperature was controlled at 25.00 ± 0.05°C. Experiments were repeated twice, and the 
experimental results were analyzed using Origin 7.0.  
 Particle size and zeta potential measurements were performed using a Malvern Zetasizer 
Nano ZS instrument. Both measurement types were performed in folded capillary cells 
(Malvern# DTS1060). The particle size distribution was determined using the non-negative least 
squares (NNLS) analysis method, where scattering was detected at 173°. Zeta potential 
measurements were carried out using laser Doppler microelectrophoresis at a frequency of 1000 
Hz. All particle size and zeta potential measurements were repeated multiple times, and the 
average is reported. 
 Surface tension measurements were performed using a Lauda TE3 tensiometer, applying 
the du Noüy ring method. The temperature was kept constant at 25 ± 0.1°C using a circulating 
water bath. Surface tension values were corrected using the method of Harkins and Jordan.14 




2.1.3 Results and Discussion 
 The results and discussion section is broken down into two parts, which discuss the 
interaction properties between gemini surfactants and DNA in the forward and in the reverse 
titration manner separately.  
 2.1.3.1 Forward Titration: Gemini Surfactant into DNA 
 The properties of complex formation between gemini surfactants and DNA was first 
evaluated from a surface perspective, using surface tension measurements. Since gemini 
surfactants are surface active agents, complex formation should differ at the liquid/air interface 
than in the bulk, when DNA is initially in excess. Such a phenomenon has been observed before 
in the literature, where surface complexes (i.e. cationic amphiphile/DNA complexes) have been 
found to form before bulk complexes.15,16  
 Vongsetskul et al. have previously investigated the properties of complexation between 
gemini surfactants and DNA at the liquid/air interface using surface tension measurements.16 
However, in their study, only the 12-6-12 gemini surfactant was used to examine the interaction 
properties with DNA.16 Therefore, the exact influence of the gemini surfactant alkyl tail length 
and the nature of the spacer group on the interaction properties with DNA at the liquid/air 
interface remains unknown. 
 Within this study, complexation between gemini surfactants and DNA was examined as a 
function of, i) the gemini surfactant alkyl tail length (12-s-12 vs. 16-s-16) and, ii) the nature of 
the spacer group (m-3-m vs. m-7-m vs. m-7NH-m). Surface tension was measured as a function 
of the gemini surfactant concentration, as the gemini surfactant of interest was titrated into a    
0.1 mM solution of salmon DNA. The combined results from this analysis are shown below in 
Figure 2.1.3.1. The surface tension plots for the titration of pure gemini surfactant into water are 
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shown for comparison purposes. Note, that in all cases, the surface tension of the pure DNA 
solution was nearly equal to that of pure water, which has been observed in the literature.15,16 
 
Figure 2.1.3.1 Surface tension plots for the titrations of gemini surfactant into water (◊), and into 
  0.1 mM salmon DNA solution (■) for A) 12-3-12, B) 12-7-12, C) 12-7NH-12, D)  



























































































































 As shown in all of the plots of Figure 2.1.3.1, there is a common pattern observed in the 
variation of surface tension as the gemini surfactant is titrated into the salmon DNA solution. 
The first immediate observation is that the surface tension starts to decrease at a significantly 
lower concentration when the gemini surfactant is titrated into the DNA solution, as opposed to 
when it is titrated into water. Such a pattern has been observed before in the literature, and is 
rationalized by the presence of DNA in solution inducing the adsorption of surfactant to the 













































gemini surfactant which attracts more surfactant to the surface.15,16 As illustrated, the surface 
tension continues to decrease with increasing surfactant concentration but then eventually 
plateaus over a concentration range. This first breakpoint is referred to as the critical aggregation 
concentration (CAC), and is considered to correspond to the concentration of surfactant where 
cooperative binding first begins in the bulk.15 The further addition of surfactant results in the 
continued binding of surfactant to DNA, and the surface tension remains fairly constant until the 
sites of DNA have been saturated with surfactant. Following this saturation point, further 
addition of surfactant leads to a lowering in the surface tension due to the adsorption of free 
gemini monomers to the surface. The surface tension continues to decrease until it reaches 
another plateau, which signifies the formation of regular gemini surfactant micelles (interface is 
saturated with gemini monomers, and thus gemini micelles begin to form in the bulk). This 
second breakpoint is represented as CMC*. 
 Overall, we see that the variation in surface tension from the titration of gemini surfactant 
into DNA solution is dependent upon the interplay of the assembly of surfactant molecules at the 
interface, and the complexation between gemini surfactants and DNA in the bulk and at the 
interface. The surface tension patterns observed in Figure 2.1.3.1 are consistent with those found 
in the literature, where it is proposed that surface aggregates form well before bulk 
aggregates.15,16 The cumulative results from this analysis are tabulated below in Table 2.1.3.1. 
 Upon evaluation of the results in Table 2.1.3.1, it is apparent that the CAC is dependent 
upon the chemical structure of the gemini surfactant. The exact influences of the gemini alkyl tail 





Table 2.1.3.1 Calculated critical concentrations for the titration of gemini surfactant into 0.1mM 
  salmon DNA solution. 
 
Surfactant Titrand 
Salmon DNA Solution Water 
CAC (mM) CMC* (mM) CMC (mM) 
12-3-12 0.028 ± 0.008 0.93 ± 0.02 0.89 ± 0.03 
12-7-12 0.028 ± 0.008  0.91 ± 0.05 0.90 ± 0.04 
12-7NH-12 0.033 ± 0.009 2.00 ± 0.09 1.17 ± 0.07 
16-3-16 0.015 ± 0.002  0.15 ± 0.05 0.024 ± 0.003 
16-7-16 0.011 ± 0.001 0.11 ± 0.01 0.026 ± 0.006  
16-7NH-16 0.015 ± 0.003 0.27 ± 0.04  0.067 ± 0.006 
 
Influence of the Gemini Alkyl Tail Length 
 As observed in Table 2.1.3.1, it is apparent that in all cases when the spacer structure is 
the same, the 16-s-16 series of gemini surfactants experienced a significantly lower CAC in 
comparison to the 12-s-12 series. To help illustrate this, the surface tension plots of the titration 
of gemini surfactant into DNA solution as a function of the spacer group are shown below in 
Figure 2.1.3.2. 
 
Figure 2.1.3.2 Surface tension plots for the titrations of gemini surfactant into 0.1mM salmon  




































 As clearly observed in all cases, the 16-s-16 series of surfactants exhibit a significantly 
lower CAC value in comparison to the 12-s-12 series. Based on this observation, it is evident that 
the length of the alkyl tail of the gemini surfactant plays a significant role in the complexation 
between gemini surfactants and DNA. More specifically, these results signify the importance of 

















































 The primary interaction between cationic amphiphiles and DNA is known to occur from 
an electrostatic interaction between the negatively charged phosphate sites of DNA and the 
cationic headgroups of the amphiphile.17 There is an additional secondary contribution to 
cationic amphiphile/DNA complexation which occurs from hydrophobic interactions.18,19 This 
hydrophobic contribution can occur from two perspectives. The first is from hydrophobic 
interactions between the alkyl tails of the amphiphile and the hydrophobic core of DNA.18 The 
other influence stems from the hydrophobic interactions between the individual amphiphile 
molecules.19 When the cationic amphiphile is initially added to the DNA solution, the first 
amphiphile molecule associated to a DNA molecule can promote more amphiphile association to 
the same DNA molecule through hydrophobic interactions between the amphiphile alkyl tails.19  
 Based on the just described contribution of hydrophobic interactions to cationic 
amphiphile/DNA complex formation, it is evident that increasing the alkyl tail length of the 
gemini surfactant should enhance these hydrophobic interactions, and therefore promote 
complexation with DNA. It is this enhanced interaction with DNA with likely accounts for the 
16-s-16 series of gemini surfactants experiencing a lower CAC with DNA, in comparison to the 
12-s-12 series. Such a pattern has been observed in the literature when the CAC was found to 
decrease as the alkyl tail length on a benzalkonium chloride surfactant was increased.20  
Influence of the Spacer Group 
 Based on the results in Table 2.1.3.1, it is evident that there is no apparent trend in the 
CAC value as a function of the different spacer groups used in this study. This is interesting 
because one would expect the nature and/or length of the spacer group to influence the 
complexation between the gemini surfactant and DNA, and consequently have an influence on 
the CAC.  
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 The m-7NH-m and m-3-m gemini surfactants are both expected to experience a more 
favourable electrostatic binding interaction with DNA, in comparison to the m-7-m gemini 
surfactant. The distances between the nitrogen centers of both the m-7NH-m and m-3-m gemini 
surfactants (5.08 and 5.25 Å, respectively)21 correlate well with the distances between the 
phosphate groups of DNA (6.5-7.1 Å),22 which can potentially make the electrostatic interactions 
between these components more favourable. In contrast, the distance between the nitrogen 
centers of the m-7-m gemini surfactants is expected to be much larger and closer to the literature 
value for the 12-8-12 surfactant, which is 11.52 Å.21 Accordingly, one could expect greater 
complexation between DNA and the m-7NH-m / m-3-m gemini surfactants, and potentially a 
lower CAC value. Interestingly, as observed in Table 2.1.3.1, this was not the case in this 
experiment.  
 
Influence of the DNA Concentration 
 The final investigation made in this surface tension study was an examination of the 
influence of the DNA concentration on complex formation between gemini surfactants and 
DNA. Figure 2.1.3.3 illustrates the variation of surface tension as the gemini surfactant is titrated 
into salmon DNA solution, at different DNA concentrations. The critical concentrations 
calculated from this analysis are tabulated below in Table 2.1.3.2. 
 
Table 2.1.3.2 Tabulated results for the influence of DNA concentration on the surface tension  
  plots for the titration of 12-7-12 into DNA solution. 
 
DNA Concentration (mM) CAC (mM) CMC/CMC* (mM) 
0 - 0.90 ± 0.04 
0.05 0.035 ± 0.006 0.92 ± 0.01  
0.1 0.026 ± 0.007 0.92 ± 0.01 




Figure 2.1.3.3 Influence of DNA concentration on the surface tension plots for the titration of  
  the 12-7-12 gemini surfactant into salmon DNA solution. 
 
 As observed in Figure 2.1.3.3, and reported in Table 2.1.3.2, the CAC was found to 
decrease as the DNA concentration increased. The behaviour can be rationalized by the fact that 
increases in the DNA concentration should enhance the occurrence of gemini/DNA 
complexation, which therefore results in this decrease of the CAC. This seems reasonable 
because as observed in Figure 2.1.3.3, when the gemini surfactant was titrated into the more 
concentrated 0.2 mM DNA solution, there is a greater initial decrease in the surface tension, 
which is likely the result of increased gemini/DNA complexation and adsorption of gemini 
surfactant to the liquid/air interface. Interestingly, previous studies in the literature have shown 
that the DNA concentration does not have an effect on the CAC; it has been reported that a 5-
fold increase in DNA concentration did not have an influence on the CAC for a benzalkonium 
chloride/DNA and a 12-6-12/DNA system.16,20  
 As also observed in Table 2.1.3.2, when the gemini surfactant was titrated into the more 
concentrated 0.2 mM salmon DNA solution, the CMC* value (which is the concentration at 


























0.90 mM in water. Such a pattern has been observed before in the literature for a benzalkonium 
chloride/DNA system, which was rationalized by the fact that an increased DNA concentration 
will require more surfactant monomers to saturate the sites on DNA, therefore prolonging the 
concentration at which regular micelles can form (i.e. the CMC* value).20 Interestingly for a 12-
6-12/DNA system, a 5-fold increase in the DNA concentration was not shown to influence the 
CMC* value.16 
 
 As a whole, this investigation examined the properties of complex formation between 
gemini surfactants and DNA at the liquid/air interface using surface tension measurements. The 
patterns observed in the surface tension plots from the titration of gemini surfactant into salmon 
DNA solution were consistent with those found in the literature, where it is proposed that surface 
aggregates form well below bulk aggregates.15,16 Our results showed that the CAC value is 
dependent on the gemini surfactant alkyl tail length, as the CAC was significantly reduced when 
the tail length was increased from 12 carbons to 16 carbons; this behaviour was rationalized in 
terms of the enhanced hydrophobic interactions as the tail length is increased. The nature of the 




 The properties of complexation between gemini surfactants and DNA was next evaluated 
using ITC. ITC measurements were carried out to investigate the enthalpy profile of 
complexation between gemini surfactant and DNA. Figure 2.1.3.4 illustrates a typical 
enthalpogram obtained for the titration of gemini surfactant into DNA solution. As shown, the 
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enthalpy of binding between gemini surfactants and DNA is endothermic, and remains fairly 
constant until the reaction endpoint, where it drops abruptly to approximately 0 kJ/mol. 
 The pattern observed in Figure 2.1.3.4 is in good agreement with those previously 
reported by Wang et al.9 In their study, the authors suggested that the lack of any peak regions in 
the enthalpograms implies that complex formation in an excess of DNA does not lead to any 
major morphological changes prior to precipitation.9 Concurrent particle size measurements were 
carried out where it was found that the particle diameter decreased as the gemini surfactant was 
added to the DNA solution, due to the condensation of DNA by the added surfactant.9 However, 
as the surfactant/DNA charge ratio approached approximately 1.0, the particle size increased 
abruptly as a result of precipitation.9 Their results were further supported by atomic force 
microscopy (AFM) images.9 Within their study, the properties of complexation was evaluated as 
a function of the gemini surfactant structure.9 
 
 
Figure 2.1.3.4 Observed enthalpies for the titration of the 12-3-12 gemini surfactant into   





















Charge Ratio (N+/P-) 
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2.1.3.2 Reverse Titration: DNA into Gemini Surfactant 
 Following the evaluation of complex formation between gemini surfactants and DNA in 
the forward titration manner, the properties of complexation was examined in the reverse order. 
This was carried out using ITC, and as shown in Figure 2.1.3.5, the enthalpy profile obtained 
from the reverse titration of DNA into gemini surfactants is dramatically different than it is in the 
forward manner, as there are two peaks present on the enthalpogram in Figure 2.1.3.5.  
 
Figure 2.1.3.5 Observed enthalpies for the titration of salmon DNA into 12-7-12 gemini   
  surfactant solution at 25°C. P-/N+ refers to the phosphate/nitrogen charge ratio. 
 
Table 2.1.3.3 Measured properties of complex formation from the titration of DNA into 12-7-12 
  gemini surfactant solution. X1 and X2 correspond to the P-/N+ charge ratios for  









10.1 18.3 0.57 15.0 0.78 
 
  Complexation between m-s-m type gemini surfactants and DNA in the reverse titration 
manner was previously investigated by Wang et al., who used a combination of ITC, AFM, 
particle size and zeta potential measurements to characterize the energetics and mechanism of 





















They proposed that complex formation in the reverse titration manner proceeded in three stages, 
i) at low DNA concentrations, the “beads on a string” structure was proposed to occur, which 
was then proceeded by ii) the reorganization of gemini/DNA complexes into more discrete, 
compact particles that were hypothesized to flocculate over a narrow region of charge ratios, 
followed by iii) the precipitation of the neutral complexes at higher DNA concentrations.9 
 Based on our experimental results, it appears that the mechanism of complex formation 
previously reported by Wang et al. is an oversimplification of the actual process. As shown in 
Figure 2.1.3.5, the enthalpogram obtained in our study showed two peaks as oppose to a single 
broad peak (which was obtained by Wang et al.), which suggests a more complex mechanism of 
association between gemini surfactants and DNA. A possible explanation for the differences in 
the enthalpograms is the greater sensitivity of the instrument used in our study, which was able 
to resolve the broad peak as previously observed by Wang et al. into two separate peaks. 
 To assist in the explanation of the enthalpy profile observed in Figure 2.1.3.5, particle 
size and zeta potential measurements were concurrently taken under identical experimental 
conditions. The combined evolution of the mean particle diameter (z-average), zeta potential, 
and observed enthalpy as DNA is titrated into gemini surfactant solution is illustrated in Figure 
2.1.3.6. Note that Figure 2.1.3.6 is broken down into 6 regions, to assist in the explanation of the 











Figure 2.1.3.6 Observed enthalpies (♦, left axis), zeta potentials (▲, left axis) and mean particle  
  diameters (●, right axis) for the titration of DNA into 12-7-12 gemini surfactant  
  solution. 
 
  
 As observed in Figure 2.1.3.6, when DNA is initially titrated into the gemini surfactant 
solution, a near constant endothermic enthalpy of 10.1 kJ/mol is observed in the system 
(designated as Region 1). Such a pattern was observed by Wang et al., where it was proposed 
that this initial region corresponds to the interaction of DNA molecules with gemini surfactant 
micelles, forming the “beads on a string structure” (see Part B in scheme 2.1.3.1 for an 
illustration of this structure).9 
 As DNA is further added to the system, an endothermic transition is observed in the 
enthalpy profile; designated as Region 2. One can postulate that within this region, the number of 
available gemini micelles that can adopt the beads on a string conformation decreases, which 
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process of transforming micelles into monomers is endothermic, i.e. the opposite sign of the 
exothermic heat of micellization.9 The enthalpy for this transition is 8.2 kJ/mol, which is in good 
agreement with the estimated enthalpy of demicellization for 12-7-12, which is predicted to be 
between 8.5 and 9.0 kJ/mole (i.e. an intermediate value of the enthalpy of demicellization for 12-
6-12 and 12-8-12).23 The Wettig group has shown that the enthalpy for this transition from the 
titration of DNA into the 12-3-12 surfactant is 20.0 kJ/mol, which is similar to the 19.3 kJ/mol 
enthalpy of demicellization for 12-3-12.24 It is worth noting that within Region 2, there are no 
significant changes in particle size and zeta potential, which further supports that this 
endothermic transition is a result of gemini demicellization.  
 As shown in Region 3, when DNA is further added to the system, there are significant 
changes in all 3 measured properties. There is an exothermic transition in the enthalpy profile, 
decrease in the zeta potential, and an increase in the particle diameter. It is postulated that within 
this region, as DNA is added, the system reaches a point where there are no additional gemini 
micelles present to interact with DNA. As such, there is a significant reorganization in the 
system, to most effectively reduce the electrostatic repulsions between the DNA molecules (see 
section D in scheme 2.1.3.1). This results in a near complete charge neutralization of the system 
(shown by the decrease in zeta potential), and the formation of large complexes as shown by the 
increases in particle diameter. The exothermic contribution observed in this region can 
potentially be attributed to the release of a substantial amount of structured water along with an 
exothermic binding between DNA molecules and gemini monomers. 
 Within Region 4, there is a second endothermic transition within the system, a near 
plateau in the zeta potential, and a further increase in the particle size. A reasonable assignment 
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for this endothermic transition is the flocculation of the gemini/DNA system. This is supported 
by the near 0 mV value of the zeta potential, and the increase in the mean particle diameter. 
 Region 5 can essentially be correlated to the precipitation of the gemini/DNA system. As 
shown, the observed enthalpy essentially decreases to 0 kJ/mol, and simply corresponds to the 
enthalpy of dilution for DNA, since no additional interactions can take place within the system.  
 
 
Scheme 2.1.3.1 Representation of the mechanism of complex formation from the titration of  
    DNA into the 12-7-12 gemini surfactant. From reference [25] 
 
 
 As a whole, it is evident that the previously reported interaction mechanism between 
gemini surfactants and DNA (by Wang et al.) in the forward titration manner appears to be an 
oversimplification of the actual process. From our work, the actual mechanism clearly involves a 









 Overall, the broad aim of this investigation was to examine the thermodynamics and 
mechanism of complexation between gemini surfactants and DNA. This was carried out in a 
series of ITC, particle size, zeta potential, and surface tension experiments, which examined the 
properties of this complexation in the forward and reverse titration manner. 
 In the forward titration manner, complexation between gemini surfactants and DNA was 
initially examined from a surface perspective using surface tension measurements. Our 
experimental results were found to be in good agreement with those previously reported, which 
suggest that surface aggregates form before bulk aggregates.15,16 Furthermore, our experimental 
results demonstrated that the CAC is dependent upon the alkyl tail length of the gemini 
surfactant (12-s-12 vs. 16-s-16), but not on the structure of the spacer group (m-3-m vs. m-7-m 
vs. m-7NH-m). Complexation in the forward sequence was further evaluated using ITC, and the 
results obtained in our study were found to be in good agreement with those previously reported 
by Wang et al.; that is, the enthalpy of binding between gemini surfactants and DNA is 
endothermic, and remains fairly constant until the reaction endpoint, where it drops abruptly to 
approximately 0 kJ/mol.9 
 In the reverse titration manner, our experimental results demonstrated that the previously 
reported mechanism of association between gemini surfactants and DNA in the literature is an 
oversimplification of the actual process. Based on a series of ITC, particle size and zeta potential 
measurements, our results demonstrated that the actual process is likely a complex series of 
linked equilibria where the system progresses from a “beads on a string” type interaction to a 
complete reorganization and the formation of neutral complexes, followed by flocculation and 
precipitation. It is worth mentioning that the Wettig group is currently evaluating the influence of 
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 Within this study, the mixing interaction between gemini surfactants and DOPE was 
investigated. Despite being just as important as the interaction with DNA, the study of the 
interactions between gemini surfactants and neutral lipids, such as DOPE, has received little 
attention. In fact, upon a literature search, the mixing interaction properties between gemini 
surfactants and DOPE has not been previously characterized. As introduced in chapter 1, the 
interaction between these two amphiphiles is of great significance because the liposome structure 
used in the preparation of gemini surfactant-based lipoplexes is a mixed aggregate of these two 
components. 
 In chapter 1 it was introduced that mixed amphiphile systems can exhibit an ideal or 
nonideal mixing behaviour in solution. Whether or not an ideal or non-ideal mixing behaviour is 
observed is dependent upon the individual structures of the amphiphiles.1 Scheme 2.2.1.1 
illustrates the chemical structure of DOPE, and it can be seen that it has a significantly different 
chemical structure in comparison to the m-s-m type gemini surfactants. Typically, mixtures of 
cationic and nonionic amphiphiles exhibit a nonideal mixing behaviour in solution due to a net 











 Within this study, the nature and strength of the interaction between gemini surfactants 
and DOPE was evaluated using Rubingh’s theory for mixed micellar systems. The interaction 
with DOPE was assessed as a function of the gemini surfactant spacer group and alkyl tail 
length. In regards to assessing the effect of the spacer group, the 16-3-16, 16-7-16 and 16-7NH-
16 gemini surfactants were used. These particular surfactants were chosen to allow us to see the 
effects of i) the spacer length (16-3-16 vs. 16-7-16), and ii) the influence of the secondary amine 
group (16-7NH-16 vs. 16-7-16) on the interaction properties with DOPE. In regards to the effect 
of the alkyl tail length, the 12-7-12, 14-7-14 and 16-7-16 surfactants were used. 
2.2.2 Experimental Procedures 
 2.2.2.1 Materials 
 The 16-3-16, 16-7-16, 16-7NH-16, 14-7-14 and 12-7-12 gemini surfactants used in this 
study were synthesized according to procedures previously reported in the literature.7,8 The 
surfactants were purified by recrystallization, and the structures were confirmed using 1H NMR 
spectroscopy (Bruker 300 MHz). The purity was confirmed by the absence of a minimum in the 
post micelle region of the surface tension versus logarithmic concentration plot. 
 1,2-dioleyl-sn-glycerophosphatidylethanolamine (DOPE) was obtained from Avanti 
Polar Lipids (Alabaster, Alabama, USA), and was used without any further purification. 
 Water for all solutions was obtained from a Millipore Synergy purification system. 
 2.2.2.2 Methods 
 To prepare the binary gemini/DOPE systems, the particular gemini surfactant studied was 
mixed with DOPE in ethanol (sonicated for 10 minutes) and then deposited as a thin film on a 
round bottom flask using a Heidolph rotary evaporator. The amphiphile mixture was then 
suspended in water using a water bath sonicator.  
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 The mixed gemini and DOPE systems were prepared in the gemini:DOPE molar ratios of 
0, 0.2, 0.4, 0.6, 0.8 and 1, to a final concentration of 2 mM for the 16-3-16, 16-7-16 and 16-7NH-
16 systems, and to a final concentration of 5 mM for the 14-7-14 and 12-7-12 systems. 
 Surface tension measurements were performed using a Lauda TE3 tensiometer, applying 
the du Noüy ring method. The temperature was kept constant at 25 ± 0.1°C using a circulating 
water bath. Surface tension was measured as a function of concentration of the single or binary 
amphiphile system. The surface tension values were corrected using the method of Harkins and 
Jordan,9 and individual surface tension measurements were repeated multiple times. 
2.2.3 Results and Discussion 
 The classical way of evaluating the interactions between amphiphiles is by determining 
the CMC of the mixed system at different molar ratios between 0 and 1.1 As discussed in chapter 
1, amphiphile mixtures do form mixed aggregates in aqueous solution, but the tendency towards 
aggregation can be different from that of the pure components.1 Within this study, the CMCs of 
the mixed gemini/DOPE systems were evaluated at the gemini:DOPE molar ratios of 0, 0.2, 0.4, 
0.6, 0.8 and 1.  
 The CMC values of the pure and mixed gemini/DOPE systems were determined using 
surface tension measurements. On a plot of surface tension versus the logarithmic amphiphile 
concentration, the CMC corresponds to the breakpoint in the curve (indicated by the arrow in 
Figure 2.2.3.1), which can be determined through linear fitting of the pre-micellar and post-
micellar regions. The surface tension plots for the mixed gemini/DOPE systems are shown below 
in Figure 2.2.3.1. It should be noted that CMC experiments for the mixed systems composed of 
DOPE with 12-7-12 and 14-7-14 were attempted but the CMCs could not be reached, despite 
using 5 mM stock solutions of these mixtures. Even though more concentrated solutions could 
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have been prepared, the high cost of DOPE made this irrational. As such, only the interactions 
between 16-3-16, 16-7-16 and 16-7NH-16 with DOPE are presented in this study, and the effect 
of the variation in surfactant alkyl tail length was abandoned.  
 
Figure 2.2.3.1 Surface tension plots for the mixed amphiphile systems of A) 16-3-16 +   
  DOPE, B) 16-7-16 + DOPE, and C) 16-7NH-16 + DOPE, at 25°C. Note, alpha  









































































 The first step in the evaluation of the interaction properties of amphiphile mixtures is to 
compare the experimental CMC values with the ideal values, at the different molar ratios studied. 
The ideal CMCs are calculated using Clint’s model for mixed micellar systems, which assumes 
that there is no net interaction between the amphiphiles (i.e. ideal mixing).10 Clint’s equation is 











         
 
where the ideal CMC of the mixture, CMCmix, can be determined by the mole fraction of 
component i in solution, αi, and the CMC of pure component i, CMCi.10  
 Figure 2.2.3.2 illustrates the comparison of the experimental CMC values with the ideal 
values for the mixed gemini/DOPE systems, as a function of αgemini; the results are tabulated in 
Table 2.2.3.1. At first glance, it is seen that in all cases, the experimental CMC values are larger 
than the ideal values. These positive deviations are indicative of a net interaction between the 
































between gemini surfactants and DOPE which results in the experimental CMCs being larger than 
the ideal CMCs.1 Two important points to note in Figure 2.2.3.2 is that the degree of deviation in 
the experimental CMC values from the ideal values appears to be dependent upon i) the structure 
of the gemini surfactant, and ii) the molecular composition in solution (i.e. αgemini). These 
interaction differences were further investigated and quantified using Rubingh’s approach. 
 
  
Table 2.2.3.1 Comparison of the measured and calculated CMC values for the single and binary 
  gemini/DOPE systems at 25°C. 
 













0 5.03 - 0 5.03 - 0 5.03 - 
0.2 292 5.98 0.2 294 6.00 0.2 291 6.17 
0.4 203 7.36 0.4 97.2 7.43 0.4 282 7.98 
0.6 77.6 9.59 0.6 56.87 9.76 0.6 120 11.3 
0.8 71.6 13.7 0.8 40.83 14.2 0.8 91.6 19.3 
1 24.2 - 1 26.2 - 1 67.0 - 
 
 
Figure 2.2.3.2 Plots of CMC versus αgemini for the A) 16-3-16 + DOPE, B) 16-7-16 + DOPE, and  
  C) 16-7NH-16 + DOPE binary systems at 25°C. Measured CMC values are  
  represented as (▲); calculated ideal CMC values from Clint’s model are   































 Rubingh’s model is an effective approach classically found in the literature to evaluate 
the nature and strength of the interactions in mixed surfactant systems. Rubingh’s model can be 
represented by the following equation 
 
𝑋𝑋12ln(CMCmix 𝛼𝛼1/CMC1𝑋𝑋1)
(1− 𝑋𝑋1)2ln(CMCmix (1− 𝛼𝛼1)/CMC2(1 − 𝑋𝑋1))








































which can be used to calculate the composition of the mixed micellar phase, where X1 is the mole 
fraction of surfactant 1 (in our case, the gemini surfactant) in the mixed micelle.1 X1 is calculated 
through an iterative process, which subsequently allows for the determination of the interaction 





          Eq. 2.2.3. 
 
 
where the variables are the same to those previously described.1 As briefly introduced in chapter 
1, the value of β is indicative of the nature and strength of the interaction between the 
amphiphiles in the mixed system. Negative values of β represent a synergistic interaction, while 
positive values of β represent an antagonistic interaction.1 Furthermore, the magnitude of β is 
indicative of the strength of the interaction; that is, the larger the magnitude of β, the stronger the 
interaction between the amphiphiles.1  
 The micellar mole fractions of the gemini surfactant in the mixed gemini/DOPE 
aggregates were first calculated using the previously described Eq. 2.2.2, and then compared to 
the ideal values calculated using Motomura’s equation. Motomura’s equation allows for the 
determination of the micelle mole fractions in the ideal state, Xideal, which can be calculated using 
the relationship given in equation 2.2.4.11 
𝑋𝑋ideal = [(𝛼𝛼1CMC2)/(𝛼𝛼1CMC2 + (1 − 𝛼𝛼1)CMC1]          Eq. 2.2.4. 
 
  
 Figure 2.2.3.3 illustrates the comparison of X1 and Xideal as a function of αgemini for the 
mixed gemini/DOPE systems. As shown in all 3 binary systems, X1 is always larger than Xideal 
over the entire range of αgemini. These positive deviations of X1 from Xideal demonstrate that the 
mixed micellar aggregates are enriched with the gemini surfactant component, and poorer in the 
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DOPE component than the intended ideal state. Interestingly, the gemini molar contribution to 
the mixed micellar aggregates (i.e. magnitude of X1) appears to be somewhat consistent over the 
entire range of αgemini, for all 3 binary systems. In other words, the solution composition (i.e. 
αgemini) appears to have only a mild effect on the composition of the mixed micellar aggregates. 
Note that X1 could not be solved for the mixed 16-7NH-16/DOPE system at a αgemini molar ratio 
of 0.2 because no convergence was found for Equation 2.2.2; such a problem has been observed 




Figure 2.2.3.3 Micellar mole fractions, X1 (▲) and Xideal (♦), as a function of αgemini for the  
  A) 16-3-16 + DOPE, B) 16-7-16 + DOPE, and C) 16-7NH-16 + DOPE binary  


































 The values of β were subsequently calculated using Eq. 2.2.3 and the results are 
illustrated graphically in Figure 2.2.3.4. The computed β values were then used to determine the 
activity coefficients of the individual amphiphiles with the equations  
lnγ1 = 𝛽𝛽(1 − 𝑋𝑋1)2          Eq. 2.2.5. 
 






























where γ1 and γ2 represent the activity coefficients of amphiphile 1 (i.e. the gemini surfactant) and 
amphiphile 2 (DOPE), respectively.1 The activity coefficients are indicative of the effect and 
contribution of the individual components in the mixed micelles.1 The determined values of γ1 
and γ2 were subsequently used to calculate the excess free energy of mixing, ΔGex0, which can be 
determined by the equation 
ΔGex0 = RT�𝑋𝑋𝑖𝑖 lnγ𝑖𝑖
2
𝑖𝑖=1
          Eq. 2.2.7. 
 






Table 2.2.3.2 Cumulative results obtained from Rubingh’s analysis for the mixed gemini/DOPE 
  systems. 
 
System αgemini X1 CMCExp. 
(x10-6M) 





0 0 5.03 - - - - 
0.2 0.66 292 11.3 3.65 137 6.26 
0.4 0.61 203 11.1 5.51 62.1 6.58 
0.6 0.61 77.6 7.47 3.17 15.7 4.42 
0.8 0.52 71.6 6.58 4.55 5.95 4.07 




0 0 5.03 - - - - 
0.2 0.67 294 11.1 3.36 142 6.07 
0.4 0.68 97.2 7.71 2.17 36.4 4.14 
0.6 0.66 56.9 5.92 1.97 13.4 3.28 
0.8 0.56 40.8 4.15 2.22 3.70 2.53 




0 0 5.03 - - - - 
0.2 - 291 - - - - 
0.4 0.70 282 9.67 2.41 111 5.05 
0.6 0.77 120 6.30 1.40 41.4 2.77 
0.8 0.71 91.6 5.06 1.55 12.4 2.60 







Figure 2.2.3.4 Interaction parameter as a function of αgemini. β values are represented as (♦) for  
  the 16-3-16/DOPE; (■) for the 16-7-16/DOPE; and (▲) for the 16-7NH-  




 The cumulative results from Rubingh’s analysis are tabulated in Table 2.2.3.2. As 
observed in this table, and as illustrated in Figure 2.2.3.4, it is confirmed that an antagonistic 
mixing interaction is present between gemini surfactants and DOPE, as implied by the positive 
values of β.1 As also observed in Table 2.2.3.2., the activity coefficients are always greater than 
unity, thus confirming a nonideal mixing behaviour, which is repulsive in nature.1 The positive 
values of the excess free energy of mixing (i.e. ΔGex0) imply that the mixed micelles are less 
stable than the individual micelles of the gemini and DOPE components.1 Interestingly, the 
mixed micelles generally become more stable as the gemini surfactant molar fraction in solution 
(i.e. αgemini) is increased.  
 The antagonistic mixing interaction experienced between the gemini surfactants and 
DOPE can potentially be attributed to the differences in the preferred curvature of the molecules 














formed by an amphiphile is based upon its critical packing parameter, P, which is a relative ratio 
of, i) the surface area occupied by a surfactant, and ii) the volume in the micelle core required for 




          Eq. 2.2.8. 
where v is the volume of the hydrophobic portion of the molecule, 𝑎𝑎0 is the area occupied by the 
headgroup, and 𝑙𝑙c  is the length of the hydrocarbon tail.15 The magnitude of P can be used to 
predict the type of aggregate structure using Table 2.2.3.3. 
 
Table 2.2.3.3 Expected aggregate characteristics in relation to the amphiphile critical packing  




General Surfactant Type Expected Aggregate Structure 
< 0.33 Simple surfactants with single chains 
and relatively large headgroups 
Spherical or ellipsoidal micelles 
0.33 – 0.5 Simple surfactants with relatively 
small headgroups, or ionic 
surfactants in the presence of large 
amounts of electrolytes 
Relatively large cylindrical or 
rod-shape micelles 
0.5 – 1.0 Double-chain surfactants with large 
headgroups and flexible chains 
Vesicles and flexible bilayer 
structures 
1.0 Double-chain surfactants with small 
headgroups or rigid, immobile chains 
Planar extended bilayer 
structures 
> 1.0 Double-chain surfactants with small 
headgroups, very large, bulky 
hydrophobic groups 
Reverse or inverted micelles 
 
 
 Since DOPE is composed of two bulky alkyl tails (as a result of the unsaturation on each 
tail), a packing parameter greater than 0.5 is expected, which suggests that DOPE forms bilayer 
structures, as observed experimentally.16 In contrast, the gemini surfactants used in this study are 
expected and known to form micellar structures.17-19 As a whole, it is apparent that gemini 
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surfactants and DOPE have different preferences in the type of aggregate structure formed once 
their respective CMCs are reached. These different preferences can potentially account for the 
antagonistic mixing interaction experienced between them. 
 As observed, there are two trends present in Figure 2.2.3.4. The first is that the strength 
of the antagonistic interaction (i.e. the magnitude of β) with DOPE is dependent upon the 
structure of the gemini surfactant spacer group. The second trend observed is that the magnitude 
of β is dependent upon the solution composition (i.e. αgemini). An explanation for these two 
patterns is proposed below. 
 
Influence of the Gemini surfactant structure on β 
 As shown in Figure 2.2.3.4, for a given solution composition (i.e. a particular value of 
αgemini), 16-3-16 experiences the most antagonistic interaction with DOPE, followed by 16-7NH-
16, and then 16-7-16. Therefore it is evident that both the gemini spacer length (16-3-16 vs. 16-
7-16), and the presence of the secondary amine group (16-7NH-16 vs. 16-7-16) influences the 
interaction properties with DOPE.  
 The influence of the spacer length on the interaction properties with DOPE can likely be 
attributed to the proximity of the cationic headgroups in the gemini surfactant. Intuitively, the 
distances between the cationic headgroups are shorter in the 16-3-16 gemini surfactant than they 
are in the 16-7-16 surfactant. As a result of the headgroups being closer in proximity in the 16-3-
16 surfactant, the mixed aggregate formed with DOPE will most likely have an increased charge 
density. This increased charge density will likely make the formation of the mixed micellar 
aggregate less favourable (because of the greater repulsive interactions), and should accordingly 
result in a stronger antagonistic interaction between the gemini surfactant and DOPE. In fact, it 
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has been reported in the literature that for gemini surfactants of the m-s-m type, when the spacer 
is less than 6 ± 1, the unfavourable and strong coulombic repulsions between the two quaternary 
ammonium headgroups results in the spacer chain being fully stretched to reduce these 
interactions.7,18,20 In contrast to the 16-3-16 surfactant, the increased spacer length for the 16-7-
16 surfactant allows for the headgroups to be at an optimal distance to balance both the repulsive 
interactions between the headgroups and the unfavourable contact of the hydrophobic spacer 
with water.7,18,20  
 The second trend observed in Figure 2.2.3.4 is that 16-7NH-16 experiences a stronger 
antagonistic interaction with DOPE, in comparison to 16-7-16. This observation can likely be 
explained in terms of the increased polar nature of the spacer group in the 16-7NH-16 gemini 
surfactant. The 16-7NH-16 surfactant contains an ionisable secondary amine group, which likely 
increases the repulsive interactions between the headgroups in the mixed gemini/DOPE 
aggregate. These enhanced repulsive interactions will likely make the formation of the 
gemini/DOPE aggregate less favourable, thus accounting for the greater antagonistic interaction 
experienced in the 16-7NH-16/DOPE system, in comparison to the 16-7-16/DOPE system. This 
interpretation is supported with results reported by Shiloach et al. who concluded that mixed 
micelle formation in binary ionic/nonionic systems is governed primarily by the electrostatic 
interactions between the amphiphile headgroups.21  
 
Influence of the solution composition on β 
 As observed in Figure 2.2.3.4, the magnitude of the interaction parameter decreases as 
the gemini surfactant molar fraction in solution (i.e. αgemini) increases. This is quite interesting 
because according to Rubingh’s theory, β should remain constant over the entire range of 
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composition.1 However, numerous studies, in particular studies of nonionic and ionic 
amphiphiles, have shown β to vary with composition.22-25 
 To offer a possible explanation for the variation of β with αgemini, one must understand 
how surfactants and lipids interact as a function of the surfactant molar fraction. In a mixed 
surfactant/lipid system, as the surfactant concentration increases, lipid vesicle solubilisation 
occurs which can be described by a three stage hypothesis; this includes a vesicular region, a 
vesicle-micelle coexistence region, and a mixed micellar region.26 Within the vesicular region, 
the surfactant concentration is low, and the surfactant monomers are partitioned between the 
aqueous solution and the lipid bilayer (note that the lipid vesicle is not yet solubilised).26 As the 
surfactant concentration is increased, surfactant monomers increasingly enter the bilayer until it 
becomes saturated.26 Further addition of surfactant subsequently results in a coexistence stage of 
surfactant monomers, mixed micelles and vesicles.26 Upon the further addition of surfactant, the 
vesicles become completely solubilised into mixed micellar aggregates.26 An illustration of this 
three stage hypothesis is shown below. Note that a reverse pattern is observed as the lipid 
concentration is increased. 
 
             Vesicular Stage                     Coexistence Stage                                       Micellar Stage 
 
Scheme 2.2.3.1 Illustration of the three stage hypothesis for the solubilisation of vesicles  





 This three stage hypothesis can be used as an aid to offer a possible explanation for the β 
variation with αgemini. At low αgemini values, the mixed gemini/DOPE system is predicted to exist 
predominantly in the vesicular stage as a result of the high DOPE concentration and the low 
gemini concentration. Within this stage, the partitioning of the gemini surfactant into the vesicle 
structure is likely not favourable because of the dicationic nature of the gemini surfactant. More 
specifically, it is not favourable for the gemini surfactant monomers to partition into the bilayer 
because the cationic gemini headgroups will increase the charge density of the aggregate 
structure, and therefore destabilize the vesicle through the increased repulsive interactions. As 
such, at lower αgemini values, one can potentially expect a larger antagonistic interaction between 
the gemini surfactant and DOPE.  
 In contrast, at high αgemini values, the mixed gemini/DOPE system will likely exist in the 
micellar stage, as a result of the high gemini concentration and the low DOPE concentration. 
Although the mixing behaviour is still antagonistic, there is a favourable contribution from the 
DOPE molecules partitioning within the micellar aggregates; the DOPE monomers are able to 
reduce the destabilizing repulsive interactions in the aggregate structure by organizing 
themselves between the cationic gemini monomers. As such, one can potentially expect the 
antagonistic interaction to be weaker at higher αgemini values.  
  
2.2.4 Conclusions 
 Within this investigation, the interaction properties between gemini surfactant and DOPE 
were examined. As discussed, the interaction between gemini surfactants and DOPE is of great 
importance because the liposome structure used in the formation of gemini surfactant-based 
DNA delivery systems is a mixed aggregate of these two components. 
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 In this study, the interaction properties between gemini surfactants and DOPE were 
evaluated using Rubingh’s theory for mixed micellar formation. It was found that in all cases, the 
interaction between the 16-3-16, 16-7-16, and 16-7NH-16 gemini surfactants and DOPE is 
antagonistic in nature. This behaviour is rationalized in terms of the differences in the preferred 
aggregate structures of these two components. The strength of the antagonistic interaction was 
found to be dependent upon the spacer group, where 16-3-16 experienced the strongest 
antagonistic interaction with DOPE, followed by 16-7NH-16 and then 16-7-16. Furthermore, the 
strength of the antagonistic interaction was found to decrease as the gemini surfactant molar 
fraction in solution was increased. 
 The combined results from this analysis are of great significance in that we were able to 
determine that both the nature of the spacer group, and the relative ratio of the gemini surfactant 
to DOPE influences the mixing interaction and stability of the mixed gemini/DOPE aggregate. 
As will be discussed in the next section of this thesis, the stability of the mixed gemini/DOPE 
aggregate carries significant implications with respect to the efficacy characteristics of gemini 
surfactant-based DNA delivery system.  
 Future studies should involve examining the effect of the gemini surfactant alkyl tail 
length on the interaction properties with DOPE. This can perhaps be conducted using 
experimental methods that do not require such large sample requirements for CMC 
determination, possibly using conductivity measurements or titration calorimetry. As well, 
transmission electron microscopy images would be useful in examining how the gemini/DOPE 





2.3 Physical Stability Analysis of Gemini Surfactant-based 




 The concluding project carried out for this study was an evaluation of the physical 
stability of gemini surfactant-based DNA delivery systems. As introduced in Chapter 1, the 
physical stability of these systems has direct implications with respect to their safety and efficacy 
characteristics within the human body, which in turn allows for an assessment of the practicality 
of these lipoplexes for gene delivery applications. Ideally, the results from this analysis should 
enable us to establish storage conditions and a shelf-life for these systems; and should 
additionally allow us to assess whether or not additional measures will have to be taken to 
modify the preparation procedure or formulation of these lipoplexes to enhance their stability 
characteristics. 
 The physical stability analysis of the gemini surfactant-based DNA delivery systems was 
performed in accordance to the FDA’s definition of the physical stability of liposome drug 
products, which is “a function of the integrity and size distribution of the lipid vesicles.”1 Based 
on this definition it is evident that there are two main evaluations that must be made in order to 
assess the physical stability of liposome drug products, i) the susceptibility of the liposome 
particles to undergo fusion and/or aggregation, and ii) the ability of the liposome to effectively 
encapsulate and protect the active therapeutic agent during delivery.1 The significance of these 
two evaluations will be addressed separately below.  
Liposome Fusion and Aggregation: 
 The susceptibility of liposomes to undergo fusion and/or aggregation can be rationalized 
by the Derjaguin-Landau-Verwey-Overbeek (DLVO) theory.2-4 The DLVO theory is represented 
by the equation, VT = VA + VR, where VT represents the total potential energy of particle 
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interaction, which is a function of the attractive forces between particles, VA, and the repulsive 
forces between particles, VR.2-4 The attractive interactions arise from van der Waals forces, while 
the repulsive interactions arise from the electrostatic repulsion between the electric double layers 
of particles.2-4 Based on the DLVO theory, the stability of a colloidal system can be rationalized 
in terms of the balance between the attractive and the repulsive forces of interaction among 
particles, as they approach each other due to Brownian motion.2-4 
 A representation of the DLVO theory is illustrated below in scheme 2.3.1.1. As shown, 
the free energy of particle interaction is dependent upon the distance of particle separation.2-4 
The attractive forces between particles predominate at smaller distances of separation, while the 
repulsive forces predominate at intermediate distances.2-4 Implicit in this representation is that 
there is an energy barrier (i.e. the primary maximum) from the repulsive forces that prevent 
particles from adhering to each other.2-4 However, if particles are able to collide with sufficient 
energy to overcome that barrier, they will adhere strongly and irreversibly together.2-4  
 
 
Scheme 2.3.1.1 Variation of the free energy of interaction with respect to particle   




 Based on the DLVO theory, it is evident the physical stability of gemini surfactant-based 
lipoplexes is dependent upon the ability of the particles to electrostatically repel each other.2-4 If 
the lipoplex particles do not effectively repel each other, fusion or aggregation may occur, 
leading to the formation of larger colloidal structures. In general, particles with zeta potentials 
more positive than +30 mV or more negative than -30 mV are considered to be stable.4 
 The particle size distribution is of great significance as it carries several implications with 
respect to the safety and efficacy characteristics of the lipoplex system within the body.6-10 In 
regards to safety, it is known that largely sized particles are capable of causing embolisms within 
the circulatory system.6 Embolism occurs when an object causes a blockage of a blood vessel as 
a result of being too large to pass through it.6 Consequently, the cells that obtain their blood 
supply from this passage are starved of oxygen and can possibly die.6 Depending on where these 
embolisms occur, the end results can be devastating and possibly fatal.6 As such, there is a 
common consensus that intravenously administered agents should not have particle sizes greater 
than 5 µm.7 In regards to the lipoplex efficacy, the particle size distribution is of significance for 
two main reasons, i) larger sized liposomes are eliminated from the circulation much more 
rapidly than smaller liposomes,8 and ii) the particle size can influence the lipoplex transfection 
efficiency, since lipoplex-cellular association and uptake are size dependent processes.9,10 
Liposome Membrane Integrity: 
 The other evaluation constituting a physical stability analysis for liposome drug products 
is an assessment of the membrane integrity. Liposomes are vesicular structures consisting of a 
bilayer membrane, where the integrity of this membrane is dependent upon the ordering and 
packing of the lipid molecules.11 Generally, this packing is determined by the curvature of the 
liposome structure,12 and by the interactions between the alkyl chains and the head groups.11 
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These interactions depend on the length and saturation of the alkyl tails, and on the structure of 
the headgroups.11 
 An insufficient packing of the lipid membrane of the lipoplex delivery system can result 
in the degradation and elimination of the incorporated plasmid DNA.13 Exposed DNA can be 
degraded enzymatically by nucleases present within the serum.13 These nucleases exert their 
effect by cleaving the phosphodiester bonds between the nucleotide subunits.13 Furthermore, 
exposed DNA has been shown to be rapidly removed from the circulation by liver uptake, which 
occurs predominantly by the liver non-parenchymal cells.14,15 The combination of these two 
factors make it evident that the membrane of lipoplex systems must be of a sufficient integrity to 
protect the incorporated DNA from the site of administration to the site of gene expression.  
 For small molecule liposome-based delivery systems, the liposome membrane integrity is 
typically examined using a dye leakage study. In our work, we are concerned with the ability of 
the lipoplex structure to protect the incorporated DNA from nucleases present in the bulk 
environment surrounding the lipoplex. As such, within this study, the membrane integrity 
characteristics of the gemini surfactant-based lipoplexes were evaluated using DNase sensitivity 
assays. These assays involved exposing the lipoplex systems to DNase I to evaluate how well the 
incorporated DNA is protected from DNase degradation. Liposomal membranes of sufficient 
integrity should offer adequate protection to the incorporated DNA from digestion 
Project Aim: 
 Collectively, the objective of this study was to assess the physical stability of gemini 
surfactant-based lipoplexes by assessing the particle size distribution and membrane integrity 
characteristics of these systems. The particle size distribution characteristics were evaluated 
using dynamic light scattering (DLS) and by performing zeta potential measurements; the 
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membrane integrity characteristics were evaluated by performing DNase sensitivity assays. The 
physical stability of these delivery systems was monitored as a function of time, temperature and 
pH. 
 The physical stability analysis was carried out on two different carrier systems. The first 
system was formulated with the 12-7NH-12 gemini surfactant, as this particular complex has 
demonstrated the highest transfection efficiency out of the complexes studied by our group.16 For 
comparison purposes, the second system evaluated was formulated with the 12-7-12 gemini 
surfactant. The 12-7NH-12 gemini surfactant differs from the 12-7-12 surfactant by the presence 
of a pH active secondary amine group in the spacer, which can potentially result in differences in 
the respective stability properties of the two systems. 
2.3.2 Experimental Procedures 
 2.3.2.1 Materials  
 The gemini surfactants used in this study were synthesized according to procedures 
previously reported in the literature.17,18 The surfactants were purified by recrystallization, and 
the structures were confirmed using 1H NMR spectroscopy (Bruker 300 MHz). The purity was 
confirmed by the absence of a minimum in the post micelle region of the surface tension versus 
log concentration plot. 
 The pGL2 plasmid was obtained from Promega (Madison, Wisconsin, USA), and 
amplified in Escherichia Coli to obtain the yields required for the stability analysis. The DNA 
used was purified with a Promega PureYield Plasmid Midiprep System (Madison, Wisconsin). 
 1,2-dioleyl-sn-glycerophosphatidylethanolamine (DOPE) was obtained from Avanti 
Polar Lipids (Alabaster, Alabama, USA), and was used without any further purification. 
 Water for all solutions was obtained from a Millipore Synergy purification system.  
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 2.3.2.2 Methods 
Preparation of gemini surfactant-based DNA delivery systems 
 The gemini surfactant-based DNA delivery systems were formulated with the respective 
gemini surfactant, DOPE, and DNA. The pGL2 plasmid was added to the gemini surfactant 
solution to obtain a gemini:DNA charge ratio of 10:1 (this ratio was previously determined to be 
the most effective)19, and the mixture was incubated for 15 minutes. DOPE vesicles were 
subsequently added to the mixture in a gemini:DOPE molar ratio of 2:5, and the final complex 
was incubated for 30 minutes.  
 The DOPE vesicles were prepared using the sonication method. DOPE and α-tocopherol 
(used as a preservative; DOPE:α-tocopherol weight ratio of 5:1) were dissolved in ethanol via 
sonication, and the mixture was then deposited as a thin film on a round bottom flask using a 
Heidolph rotary evaporator. The mixture was next suspended in an isotonic sucrose solution (at 
pH 9) using a water bath sonicator (60°C for 3 hours), and the DOPE vesicles were then filtered 
through 0.45 μm filters. 
Particle Size and Zeta Potential Measurements 
 Particle size and zeta potential measurements were both carried out using a Malvern 
Zetasizer Nano ZS instrument. The particle size distribution was determined using the NNLS 
analysis method, where scattering was detected at 173°. Size measurements were performed in 
disposable polystyrene cuvettes. Zeta potential measurements were carried out using laser 
Doppler microelectrophoresis at a frequency at 1000 Hz. Measurements were performed in 
folded capillary cells (Malvern# DTS1060). All particle size and zeta potential measurements 
were repeated multiple times, and the average is reported. Significant differences between 
particle size and zeta potential results were assessed using a t-test at a 95% confidence level. 
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DNase Sensitivity  
 The DNase sensitivity assays were carried out by incubating the desired lipoplex system 
with DNase I (1 unit DNase I per 1 μg DNA) and the DNase reaction buffer (composed of Tris-
HCl, MgSO4, and CaCl2), for 30 minutes at 37°C. Following the 30 minute exposure period, the 
DNase I enzymes were inactivated by the addition of the DNase stop solution (composed of 
ethylene glycol tetraacetic acid), and then denatured by incubating the complexes at 60°C for 10 
minutes. The liposomal membranes were then disrupted through the addition of a 
phenol/chloroform mixture (1:1, v/v), and the aqueous DNA phase was separated from the 
liposome-forming components through centrifugation.  
 The extent of DNA degradation by DNase I was assessed using gel electrophoresis. An 
aliquot of the extracted DNA phase was loaded onto a 0.8% (w/v) agarose containing 0.5 μL/mL 
ethidium bromide. Electrophoresis experiments were carried out for 1 hour at 100V, in TBE 
buffer solution. The resulting gels were analyzed using an Alpha Innotech Gel Imaging System. 
 Since DNase sensitivity assays on gemini surfactant-based lipoplexes were never carried 
out in the past, the experimental procedure used was first validated. There were two aims in the 
validation process: i) to ensure that only intact DNA fragments can be visualized on the imaged 
gel, and ii) to ensure that the phenol/chloroform extraction method can effectively separate DNA 
from the liposome forming components  
 As shown in Figure 2.3.2.1, a series of controls was ran to ensure that only intact DNA 
fragments can be visualized on the imaged gel. The main conclusions drawn from this gel are, i) 
only DNA separated from the liposome or gemini surfactant can effectively be visualized, and ii) 













 The aim of the second validation test was to ensure that the chloroform/phenol extraction 
method can be used to effectively separate DNA from the gemini surfactant and DOPE 
components. To conduct this, DNA separated from a gemini surfactant-based lipoplex using the 
chloroform/phenol extraction method was compared to an aqueous solution containing an equal 
concentration of DNA. The results are illustrated below in Figure 2.3.2.2, and as shown, the 
chloroform/phenol extraction method allowed for the effective separation of DNA from the 
gemini/DOPE liposome. This was confirmed by a 5.2% variation in the band intensities shown in 
Figure 2.3.2.2.  
 







1 Aqueous DNA solution 
2 DNA extracted from gemini 




1 pGL2 DNA plasmid 
2 gemini surfactant-based lipoplex 
3 gemini surfactant 
4 DOPE 
5 gemini surfactant + DNA   
(gemini:DNA charge ratio = 10:1) 
6 DNA exposed to DNase I 
  1         2        3        4        5        6        
      1             2      
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2.3.3 Results and Discussion 
Physical Stability as a Function of Time and Temperature: 
 12-7NH-12 Complex 
 The physical stability of the gemini surfactant-based DNA delivery systems was first 
assessed as a function of time and temperature. Figures 2.3.3.1 and 2.3.3.2 illustrate the 
evolution of the mean particle diameter and zeta potential of the 12-7NH-12 lipoplex system as a 
function of time, during storage at 4, 22 and 60°C.  
 As shown in Figure 2.3.3.1, there is initially no apparent trend in the evolution of the 
mean particle diameter over time as a function of the storage temperature. However, after 96 
hours of storage, the lipoplex system stored at 4°C was found to have a consistently and 
significantly (p < 0.05) smaller mean particle diameter in comparison to the lipoplex systems 
stored at 22 and 60°C. As well, after 144 hours, the mean particle diameter of the system stored 
at 22°C was found to be significantly (p < 0.05) smaller than that of the system stored at 60°C 
(note that particle size measurements of the system stored at 60°C was halted after 2 weeks due 
to discoloration of the system and the formation of visible precipitates). Over the 5 week 
interval, the lipoplex stored at 4°C showed no significant changes in the mean particle diameter, 
which always remained below 190 nm. The mean particle diameter of the system stored at 22°C 
was found to increase from 161.4 to 234.6 nm during this 5 week interval.  
 Figure 2.3.3.2 illustrates the evolution of the zeta potential as a function of time, for the 3 
storage temperatures. As shown, there is initially no apparent trend in the variation of the zeta 
potential before 48 hours of storage. However, after 72 hours, the zeta potential of the lipoplex 
system stored at 60°C was found to be consistently and significantly (p < 0.05) smaller than the 
zeta potentials of the systems stored at 4 and 22°C. Furthermore, the zeta potential of the system 
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stored at 22°C was found to be consistently and significantly (p < 0.05) smaller than that of the 
system stored at 4°C after 2 weeks of storage. However, over the 5 week storage interval, the 
zeta potentials of the systems stored at 4 and 22°C were always found to be larger in magnitude 
than +30 mV, characteristic of a stable colloidal system. 
 
Figure 2.3.3.1 Variation of the mean hydrodynamic diameter as a function of time for the         
  12-7NH-12 lipoplex system stored at 4°C (♦), 22°C (●), and 60°C (▲) over a time 

































































Figure 2.3.3.2 Variation of the zeta potential as a function of time for the 12-7NH-12 lipoplex  
  system stored at 4°C (♦), 22°C (●), and 60°C (▲) over a time period of A) 1  






 12-7-12 Complex 
 For the 12-7-12 lipoplex, the evolution of the mean particle diameter as a function of time 








































mean particle diameter of the system stored at 60°C was found to increase over time, and became 
significantly (p < 0.05) larger than the particle diameters of the systems stored at 4 and 22°C 
after 72 hours of storage. The mean particle diameter of the system stored at 22°C was found to 
be consistently and significantly (p < 0.05) larger than that of the system stored at 4°C after 120 
hours of storage. Over the 5 week storage interval, the system stored at 4°C was always found to 
have a mean particle diameter less than 150 nm. In regards to the system stored at 22°C, the 
mean diameter was found to increase to 207.1 nm over the 5 weeks interval. 
 Overall, a general pattern is apparent in both of the 12-7-12 and 12-7NH-12 lipoplexes; 
aggregation is more prevalent as the storage temperature of the lipoplex system is increased. This 
particular behaviour is expected because increases in the temperature of the system will result in 
an increase of the thermal energy of lipoplex particles in solution. As a result, more particles are 
able to collide with sufficient energy to overcome the primary maximum energy barrier (as 
described by the DLVO theory), thus resulting in increased aggregation.2-4 
 The evolution of the zeta potential for the 12-7-12 lipoplex as a function of time for the 3 
storage temperatures is illustrated in Figure 2.3.3.4. As observed, the zeta potential of the 
lipoplex system stored at 60°C was found to decrease with time, and was additionally found to 
be consistently and significantly (p < 0.05) smaller than those of the systems stored at 4 and 
22°C after 72 hours of storage. The reason for this decrease in zeta potential is unknown, but can 
most likely be attributed to changes in the structural organization of the lipoplex particles over 
time. A similar pattern has been observed in the literature for a cationic solid lipid 
nanoparticle/DNA vector stored at 40°C, where the zeta potential of the system was found to 
decrease significantly after a 6 month storage period.20 For the lipoplex systems stored at 4 and 
22°C, there is no apparent trend in the evolution in the zeta potential over time; in all cases the 
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zeta potential was larger in magnitude than +30 mV. Such a pattern has been observed in a 
DOTAP/DOPE/DNA lipoplex system, where no apparent trends in the zeta potentials were 
observed over a 104 week interval when the lipoplex systems were stored at various 
temperatures between -20 and 60°C.21  
 
Figure 2.3.3.3 Variation of the mean hydrodynamic diameter as a function of time for the         
  12-7-12 lipoplex system stored at 4°C (♦), 22°C (●), and 60°C (▲) over a time  




































































Figure 2.3.3.4 Variation of the zeta potential as a function of time for the 12-7-12 lipoplex  
  system stored at 4°C (♦), 22°C (●), and 60°C (▲) over a time period of A) 1  
















































 During the evaluation of the particle size distribution characteristics of the gemini 
surfactant-based lipoplex systems, the membrane integrity properties were simultaneously 
evaluated using DNase sensitivity assays. Figures 2.3.3.5 and 2.3.3.6 illustrate the DNase 
sensitivity of the gemini lipoplex systems as a function of time during storage at 4°C.  
 
 
Figure 2.3.3.5 DNase sensitivity as a function of storage time for the 12-7NH-12 lipoplex system 
  over a time period of A) 1 week, and B) 5 weeks. Note, lane 1 represents the  
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Figure 2.3.3.6 DNase sensitivity as a function of storage time for the 12-7-12 lipoplex over a  
  time period of A) 1 week, and B) 5 weeks. Note, lane 1 represents the standard  
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 As shown in both Figures 2.3.3.5 and 2.3.3.6, the gemini lipoplexes became more 
sensitive to DNase degradation over time. For both of the 12-7-12 and 12-7NH-12 lipoplexes, no 
evident bands were detected after 4 weeks of storage, implying a near complete degradation of 
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 The increased sensitivity of the gemini lipoplexes to DNase degradation over time can 
potentially be attributed to the dissociation of the lipoplex structure. A previous study conducted 
by Lai et al. has suggested that lipoplex formulations dissociate over time, as supported by the 
formation of less dense particles with increasing time of storage.22 Despite increases in the 
geometric sizes of the DOTIM/cholesterol/DNA lipoplexes used in their study (note that in some 
cases, the geometric sizes remained fairly constant), the molar masses of the particles were found 
to decrease over time.22  
 Although it is unknown whether or not dissociation occurs in the gemini lipoplexes, the 
antagonistic mixing interaction between gemini surfactants and DOPE can possibly offer a 
driving force for this phenomenon. As revealed in Chapter 2.2 of this thesis, the mixing 
interaction between gemini surfactants and DOPE is repulsive in nature, which was rationalized 
in terms of the differences in the preferred curvature of the aggregate structures of these two 
amphiphiles in solution. Is it therefore reasonable that over time, the mixed gemini/DOPE 
aggregates may potentially dissociate into gemini-rich aggregates and DOPE-rich aggregates. In 
the literature, mixed amphiphile systems exhibiting antagonistic mixing interactions have been 
shown to demix into separate single component-rich aggregate structures.23-27 
 Lai et al. additionally showed that the rate of lipoplex dissociation increased as the 
storage temperature was increased.22 To examine the temperature dependence of the lipoplex 
membrane integrity, DNase sensitivity was examined as a function of storage temperature (4, 22 
and 60°C) over a time period of 24 hours; an illustration is shown below in Figure 2.3.3.7. As 
observed, the lipoplex delivery system stored at 60°C demonstrated an inferior membrane 
integrity, in comparison to the other two systems stored at 22 and 4°C. This was shown by the 
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increased sensitivity of the lipoplex system stored at 60°C to DNase degradation, as there were 
no evident bands in lanes of the gels corresponding to these complexes. 
 
Figure 2.3.3.7 DNase sensitivity as a function of storage temperature over a time period of 24  
  hours for the A) 12-7NH-12 lipoplex, and B) 12-7-12 lipoplex. Note that lane 1  
  represents the standard amount of DNA in each lipoplex. 
 








 As a whole, it is evident that the physical stability of gemini surfactant-based DNA 
delivery systems is dependent upon both the time and temperature of storage. As shown by the 
particle size distribution results, lipoplex aggregation occurs over time, and becomes more 
prevalent as the storage temperature is increased. Upon examination of the DNase sensitivity 
assays, it is evident that the gemini lipoplex systems becomes more sensitive to DNase 
degradation over time, and as the storage temperature is increased. 
 The combined results from this analysis suggest that the overall physical stability of the 
gemini surfactant-based lipoplex systems is limited by the membrane integrity of the liposome 
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exposure of the lipoplexes to DNase resulted in no apparent DNA bands in the gel lanes. 
However, as shown in Figures 2.3.3.1 and 2.3.3.3., the mean particle diameter was found to 
remain fairly consistent over this 4 week interval. 
 
Physical Stability as a Function of pH 
 The physical stability of the gemini surfactant-based lipoplex systems was further 
investigated as a function of pH. Figures 2.3.3.8 and 2.3.3.9 illustrate the evolution of the mean 
particle diameter and zeta potential as a function of pH, for the 12-7NH-12 and 12-7-12 lipoplex 
systems respectively.  
 For the 12-7NH-12 lipoplex system, the mean particle diameter was found to increase as 
the pH decreased. In contrast, for the 12-7-12 lipoplex, there is no apparent trend in the evolution 
of the mean particle diameter as a function of pH. Based on these two observations, it is evident 
that the secondary amine group on the spacer of the 12-7NH-12 surfactant is responsible for the 
pH-dependent size distribution of the 12-7NH-12 based lipoplex system. It has been previously 
reported that the pKa for this secondary amine group is 5.0 ± 0.4.16 Therefore, upon acidification 
of the system to pH values less than approximately 5, the protonation of this secondary amine 
group should result in increased headgroup repulsive interactions in the aggregate structure, 
which likely accounts for the observed increases in particle size. As shown in Figure 2.3.3.8A, 
the mean diameter of the 12-7NH-12 lipoplex was found to increase at pH 6, which is close to 
the pKa value of the secondary amine group in the spacer. 
 Figures 2.3.3.8B and 2.3.3.9B illustrate the dependence of the lipoplex zeta potential as a 
function of pH. As shown in both of the 12-7NH-12 and 12-7-12 lipoplexes, the zeta potential 
decreased as the pH of the system was increased. Such a pattern has been observed before in the 
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literature, and is rationalized by the increased counterion binding of hydroxide ions to the 
lipoplex particle as the pH becomes more basic.16 As a result, charge screening of the lipoplex 
particles occurs, which results in the observed decrease in zeta potential. 
 
Figure 2.3.3.8 Variation of the A) mean hydrodynamic diameter, and B) Zeta potential as a  

























































Figure 2.3.3.9 Variation of the A) mean hydrodynamic diameter, and B) Zeta potential as a  







 The membrane integrity characteristics of the lipoplex systems as a function of pH are 
illustrated below in Figure 2.3.3.10. Interestingly, it is observed that for both of the 12-7NH-12 

















































significantly as the pH is decreased to a value of approximately 2, as there are no visible bands 
on the gel for this treatment. The exact reason for this observation is unknown, but can 
potentially be attributed to a pH-dependent change in the packing arrangements of the lipoplex 
structure, which makes the incorporated DNA more susceptible to degradation by DNase. DNA 
depurination, which is the removal of purine bases (adenine or guanine) from the deoxyribose 
moiety by hydrolysis of the glycosidic bond, may also provide another explanation for the 
observed behaviour at pH 2.28 As found in the literature, the rate of depurination is pH 
dependent, and is significantly increased under acidic conditions (i.e. the hydrolysis of the 
purine-deoxyribose glycosyl bond is acid-catalyzed).28  
 
 
Figure 2.3.3.10 DNase sensitivity as a function of pH for the A) 12-7NH-12 lipoplex, and          
    B) 12-7-12 Lipoplex. Note that lane 1 represents the standard amount of DNA in 
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 Within this investigation, a preliminary physical stability analysis on gemini surfactant-
base lipoplex systems was performed. The physical stability was assessed by examining the 
changes in the particle size distribution and membrane integrity of the gemini lipoplex system as 
a function of time, temperature and pH. 
 With respect to the particle size distribution, the gemini lipoplexes were found to 
aggregate over time, where the rate of aggregation was dependent upon the storage temperature. 
Lipoplex systems stored at higher temperatures were found to aggregate at a faster rate. In terms 
of the membrane integrity, the lipoplex systems were found to become more sensitive to DNase 
degradation over time, and as the storage temperature was increased.  
 Based on the combined experimental results from this analysis, it is evident that the 
physical stability of gemini lipoplex systems is limited by the membrane integrity. As shown in 
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of DNase protection after 4 weeks of storage. In contrast, there were no dramatic changes in the 






























Interactions between Gemini surfactants and 





































 As discussed extensively in Chapter 1, the unique solution properties of gemini 
surfactants make them intriguing candidates for use in pharmaceutical formulations. In order to 
further effectively assess the pharmaceutical applications of gemini surfactants, an understanding 
of their interactions with other surfactants typically found in pharmaceutical formulations is 
essential. Within this investigation, the interactions between gemini surfactants and the nonionic 
polyoxyethylene (20) sorbitan ester family of surfactants (known as the Tween surfactants) was 
examined. The Tween surfactants are perhaps the most commonly used surfactants in 
pharmaceutical formulations, in large due to their nontoxicity characteristics and approval as 
food grade surfactants.1 
 In this study, the interaction properties between the 16-3-16 gemini surfactant and a 
homologous series of polyoxyethylene (20) sorbitan ester surfactants having laurate (Tween 20), 
stearate (Tween 60) or oleate (Tween 80) alkyl tails was evaluated. The chemical structures of 
Tween 20, 60 and 80 are shown below in Scheme 3.1.1. As observed, all three Tweens share the 
same headgroup, but differ in the length and saturation of their alkyl tails. There are 12 carbons 
in the alkyl tail of Tween 20, which is in contrast to the 18 carbons in the alkyl tails of Tween 60 
and Tween 80. Tween 80 differs from Tween 60 by the presence of an unsaturation at carbon 9 
on the alkyl tail. 
 
Scheme 3.1.1 Chemical structures of A) Tween 20, B) Tween 60, and C) Tween 80. Note in all  




















 In this investigation, the interaction properties between the gemini and Tween surfactants 
were examined and analyzed using Clint’s, Rubingh’s and Motomura’s theories of mixed 
micellar systems. These theories were previously discussed in Chapter 2.2 of this thesis. 
3.2 Experimental Procedures 
 3.2.1 Materials 
 The polyoxyethylene (20) sorbitan monolaurate (Tween 20), polyoxyethylene (20) 
sorbitan monostearate (Tween 60), and polyoxyethylene (20) sorbitan monooleate (Tween 80) 
surfactants were obtained from PCCA (Houston, Texas) and were used without any further 
purification.  
 The 16-3-16 gemini surfactant used was synthesized according to procedures previously 




























was confirmed using 1H NMR spectroscopy (Bruker 300 MHz). The purity was confirmed by the 
absence of a minimum in the post micelle region of the surface tension versus log concentration 
plot. 
 Water for all solutions was obtained from a Millipore Synergy purification system. 
 3.2.2 Methods 
 Surface tension measurements were performed using a Lauda TE3 tensiometer, applying 
the du Noüy ring method. The temperature was kept constant at 25 ± 0.1°C using a circulating 
water bath. Surface tension values were corrected using the method Harkins and Jordan.4 
Individual surface tension measurements were repeated multiple times. The CMC was 
determined by the break in the plot of surface tension versus concentration.  
 Mixed 16-3-16 and Tween solutions were prepared in the molar ratios of 0, 0.2, 0.4, 0.6, 
0.8 and 1 (to a final concentration of 1 mM), and separately titrated into water. Surface tension 
was measured as a function of concentration of the single or binary amphiphile system. 
3.3 Results and Discussion 
 The results from this investigation were analyzed identically to those described in 
Chapter 2.2 of this thesis. Briefly, the CMCs of the mixed gemini/Tween systems were evaluated 
at different molar ratios between 0 and 1, using surface tension measurements (see Figure 3.3.1). 
The determined CMC values were then compared to the ideal values calculated using Clint’s 
equation (Eq. 2.2.1). Rubingh’s approach was subsequently used to calculate the mole fractions 
in the mixed micelle, and the results were compared to those in the ideal state as determined by 
Motomura’s equation. Rubingh’s approach was further used to calculate the interaction 




Figure 3.3.1 Surface tension plots for the mixed amphiphile systems of A) Tween 20 + 16-3- 
  16, B) Tween 60 + 16-3-16, and C) Tween 80 + 16-3-16, at 25°C.5 Note, alpha  


























































































 In Figure 3.3.2, the relationship between the CMC values of the mixed gemini/Tween 
systems and the molecular composition in solution is shown. The solid lines represent the ideal 
CMC values calculated using Clint’s equation, while the dotted lines represent the determined 
experimental CMC values. As illustrated, the variations of the CMC values with composition 
appear to be different depending on the Tween surfactant in the mixture. In particular, the 
experimental CMC values for the Tween 20/16-3-16 system were initially larger than the ideal 
values; however, the experimental CMC values became smaller than the ideal values at larger 
mole fractions of Tween 20. For both the Tween 60 and Tween 80/16-3-16 systems, the 




Figure 3.3.2 Plots of CMC versus αTween for the A) Tween 20 +16-3-16, B) Tween 60 + 16-3- 
  16, and C) Tween 80 + 16-3-16 binary systems at 25°C.5 Measured CMC values  
  are represented as (▲); calculated ideal CMC values from Clint’s model are  

































Table 3.3.1 Comparison of the measured and calculated CMC values for the single and binary 
  16-3-16 and Tween systems at 25°C.5 Literature values are in brackets. 
 













0 22.6 - 0 22.6 - 0 22.6 - 
0.2 24.5 18.8 0.2 2.15 17.4 0.2 7.34 19.3 
0.4 21.5 16.1 0.4 3.50 14.1 0.4 10.5 16.9 
0.6 10.3 14.1 0.6 5.59 11.9 0.6 9.29 15.0 
0.8 10.5 12.5 0.8 6.91 10.3 0.8 7.01 13.5 





































 The evident deviations in the experimental CMC values from the ideal CMC values 
observed in Figure 3.3.2 suggest a nonideal mixing behaviour between the gemini and Tween 
surfactants.7 As discussed in Chapter 1, a nonideal mixing behaviour is indicative of a net 
interaction between the amphiphiles, which can be attractive or repulsive.7 The nature and 
strength of these interactions in the mixed gemini/Tween systems were evaluated and 
characterized using Rubingh’s model for mixed micellar formation.  
 The mole fractions of the Tween surfactant in the mixed micelles were first determined 
using the previously described equation 2.2.2. These values were then compared to the ideal ones 
as calculated using Motomura’s equation (Eq. 2.2.4). Figure 3.3.3 illustrates the comparison of 
X1 and Xideal as a function of αTween for the mixed Tween/16-3-16 systems. It can be seen that in 
the case of the Tween 60/16-3-16 and Tween 80/16-3-16 systems, X1 was found to deviate 
positively from Xideal until αTween approached approximately 0.35. These initial positive 
deviations from Xideal demonstrate that within these low αTween regions, the mixed micelles are 
richer in the Tween surfactants and poorer in 16-3-16 than its intended ideal state. For αTween 
values greater than approximately 0.35, the mixed micelles became enriched with the 16-3-16 
surfactant. In the case of the Tween 20/16-3-16 system, there is no apparent trend in the 
deviation of X1 from Xideal. It can be seen that the mixed micelle is initially enriched with 16-3-16 
at low αTween values; and becomes enriched again with 16-3-16 at higher αTween values. 
 The interaction parameters for the mixed Tween/16-3-16 systems were subsequently 
calculated using equation 2.2.3, and the results are illustrated graphically in Figure 3.3.4. The 





Figure 3.3.3 Micellar mole fractions, X1 (▲) and Xideal (♦), as a function of αTween for the A)  
  Tween 20 + 16-3-16, B) Tween 60 + 16-3-16, and C) Tween 80 + 16-3-16 binary  
















































 The cumulative results of Rubingh’s analysis for the mixed Tween/16-3-16 systems are 
tabulated in Table 3.3.2. Upon initial inspection, it is evident that there is a synergistic mixing 
interaction present in the Tween 60/16-3-16 and Tween 80/16-3-16 systems, due to the negative 
values of β over all solution compositions. Furthermore, the activity coefficients (γ1, γ2) for these 
two systems were always found to be less than unity, thus confirming a nonideal mixing 
behaviour which is attractive in nature.7 As well, the negative values for the excess free energies 
of mixing (ΔGex0) suggest that the mixed micelles in these systems are more stable than the 
micelles of the individual components.7 For the mixed Tween 20/16-3-16 system, it is evident 
that there is an initial slight antagonistic interaction at low αTween values, due to the positive 
values of β. However, the interaction becomes synergistic at αTween values of 0.6 or higher. 
 
 
Figure 3.3.4 Interaction parameter as a function of αTween. β values are represented as (♦) for  
  the Tween 20; (■) for the Tween 60; and (▲) for the Tween 80 binary systems  

















Table 3.3.2 Results obtained from Rubingh’s analysis for the mixed Tween and 16-3-16  
  systems.5 
 
System αTween X1 CMCExp. 
(x10-6M) 





0 0 22.6 - - - - 
0.2 0.17 24.5 1.4 2.6 1.0 0.47 
0.4 0.67 21.5 1.2 1.1 1.7 0.67 
0.6 0.66 10.3 -1.5 0.84 0.53 -0.83 
0.8 0.79 10.5 -1.3 0.94 0.44 -0.54 




0 0 22.6 - - - - 
0.2 0.48 2.15 -8.5 0.10 0.15 -5.2 
0.4 0.53 3.50 -5.7 0.29 0.20 -3.5 
0.6 0.62 5.59 -3.5 0.60 0.26 -2.1 
0.8 0.74 6.91 -2.7 0.83 0.23 -1.3 




0 0 22.6 - - - - 
0.2 0.44 7.34 -4.1 0.28 0.46 -2.5 
0.4 0.53 10.5 -1.9 0.65 0.59 -1.2 
0.6 0.62 9.29 -2.2 0.73 0.43 -1.3 
0.8 0.67 7.01 -3.7 0.68 0.19 -2.0 
1 1 12.3 - - - - 
 
 
 Synergistic interactions are typically observed in mixed ionic and nonionic surfactant 
systems, and have been rationalized by Maeda et al. to be the result of the insertion of nonionic 
surfactant monomers between the ionic surfactant monomers in the mixed micelle, which results 
in an overall reduction of the electrostatic repulsive interactions between the headgroups.8 As a 
result of these reduced repulsive interactions, a more stabilized micelle is formed.8 This 
explanation likely accounts for the general synergism experienced in the mixed gemini/Tween 
systems, which is likely attributed to the insertion of the nonionic Tween monomers between the 
cationic gemini monomers in the mixed micelle. It is interesting to point out that some authors 
have indicated that the stabilization of mixed micelles composed of cationic surfactants and 
nonionic surfactants consisting of polyoxyethylene groups can be explained on the basis of the 
ion-dipole interactions occurring between the ether oxygens and the cationic headgroups.9,10 
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Although this is a possible contribution, the stabilization that occurs between the Tween 
surfactants and 16-3-16 is most likely consistent with the electrostatic stabilization that occurs 
from the insertion of the Tween monomers between the 16-3-16 monomers in the mixed micelle. 
There may, however, also be a stabilizing interaction between the dicationic headgroup of 16-3-
16, and the polar ethylene oxide chain and sorbitan ring of the Tween surfactants. 
 The magnitudes of β ranged between -2.7 and -8.5 for the Tween 60/16-3-16 system, and 
between -1.9 and -4.1 for the Tween 80/16-3-16. These values are consistent with those typically 
observed in mixed m-s-m gemini and nonionic systems,11-14 and are in good agreement with 
those generally observed for mixed ionic/nonionic systems.15 For the Tween 20/16-3-16 system, 
the magnitude of β was found to deviate slightly around 0 with αTween, thus suggesting a near 
ideal mixing behaviour for this system. Such an observation has been observed before in the 
literature for mixed cationic n-alkylpyridinium bromide and nonionic nonylphenyl ethoxylate 
surfactant systems.16 
 Upon closer examination of the experimental results, it is clear that the magnitude of β is 
dependent upon the chemical structure of the Tween surfactant in the binary system. As shown in 
Figure 3.3.4, the Tween 60 surfactant was generally found to experience the strongest synergistic 
interaction with 16-3-16, followed by Tween 80 and Tween 20. The disparities in interaction 
between 16-3-16 and the Tween surfactants can be rationalized using Maeda’s theory for mixed 
surfactant systems. According to Maeda, the transfer process of an ionic surfactant monomer to a 
nonionic micelle will consist of two distinct contributions, i) the interaction between the 
surfactant headgroups, and ii) the interaction between the hydrocarbon chains of the respective 
surfactants.8 In our case, since the headgroups of the Tween surfactants are the same (see 
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Scheme 3.1.1), any differences in β can most likely be attributed to differences in the 
hydrocarbon tail of the Tween surfactant.  
 As shown in Figure 3.3.4, it is observed that for a fixed αTween value, the stability of the 
mixed micelle (i.e. magnitude of β) was found to decrease as the alkyl chain length of the Tween 
surfactant is decreased from 18 carbons (Tween 60/Tween 80) to 12 carbons (Tween 20). 
Furthermore, the stability of the mixed system was observed to generally increase as the 
unsaturation in the Tween alkyl tail is removed (Tween 60 versus Tween 80). This mixed 
micellar stability dependence on the alkyl chain length results from a more stabilized packing of 
the Tween 60/Tween 80 monomers with the 16-3-16 monomers in the mixed micelle, in 
comparison to that in the Tween 20/16-3-16 system. The alkyl tail lengths of Tween 60/Tween 
80 only differ from 16-3-16 by 2 methylene units, which is in contrast to a difference of 4 
methylene units in the Tween 20 and 16-3-16 system. Therefore, in the mixed Tween 60/16-3-16 
and Tween 80/16-3-16 systems, there is likely an enhanced packing efficiency in the micelle, in 
comparison to the Tween 20/16-3-16 system. In fact, in the literature it has been observed that 
synergistic interactions between surfactants are enhanced when their alkyl tail lengths are 
matched;17 this was rationalized by the findings of Shiao et al. who reported that there is an 
increased order, tighter packing and greater stability of the mixed micelle, when the length of 
adjacent hydrocarbon chains are the same.18 With regard to the effect of the alkyl tail saturation, 
Tween 80 experiences a weaker synergistic interaction with 16-3-16 (in comparison to the 
Tween 60/16-3-16 system) as a result of the hampered packing efficiency of the alkyl chains in 
the micelle by the cis double bond present in the oleate tail of Tween 80.  
 It is important to note that in all cases, the magnitude of β was found to vary with the 
molar fraction of the Tween surfactant (see Figure 3.3.4). According to Rubingh’s theory, the 
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interaction parameter should remain constant over the entire range of composition.7 However, 
numerous studies, in particular, studies of mixed cationic and nonionic systems have found β to 
vary with composition.19-22 As illustrated in Figure 3.3.4, there is no apparent trend in the 
magnitude of β with composition, which has been observed in the literature.14,21,22  
3.4 Conclusions 
 Within this study, the nature and strength of the interactions between the 16-3-16 gemini 
surfactant and a homologous series of Tween surfactants was investigated. The results 
demonstrate a synergistic mixing behaviour between the cationic gemini and the nonionic Tween 
surfactants, which can be explained in terms of the decreased electrostatic repulsions between the 
headgroups due to the insertion of the Tween monomers between the cationic gemini monomers 
in the mixed micelle. The longer chain Tween 60 and Tween 80 surfactants were found to 
experience a stronger synergistic effect with 16-3-16, in comparison to the shorter chain Tween 
20. Furthermore, the presence of the unsaturation in the alkyl tail of the Tween 80 surfactant was 
found to decrease the strength of the synergistic interaction with 16-3-16, in comparison to the 
Tween 60/16-3-16 system. 
 The results from this analysis are of interest for the applications of gemini surfactants in 
pharmaceutical preparations. As discussed in chapter 1, gemini surfactants possess numerous 
unique solution properties which make them advantageous for use in pharmaceutical 
formulations. These advantages coupled with the fact that gemini surfactants can potentially 
demonstrate strong synergistic mixing interactions with the commonly used Tween surfactants, 
further enhances the attractiveness of the use of gemini surfactants in pharmaceutical 
preparations. The synergistic interaction experienced between gemini and Tween surfactants can 
reduce the total amount of these surfactants required for a particular application, which in turn 
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reduces costs and environmental impact. Furthermore, the stabilized gemini/Tween mixed 






















































 Within this work, two distinct projects were carried out to assess the pharmaceutical 
applications of gemini surfactants. The objective of the first project was to assess the 
applications of gemini surfactants as transfection agents for nonviral gene delivery by evaluating 
the physical stability characteristics of gemini surfactant-based lipoplex systems. Prior to this 
investigation, the physicochemical properties of the lipoplex system were evaluated by 
investigating the interactions between gemini surfactants and DNA, and between gemini 
surfactants and DOPE. 
 In chapter 2.1, the interaction between gemini surfactants and DNA was investigated 
using a combination of ITC, particle size, zeta potential and surface tension measurements. In the 
forward titration manner (i.e. gemini surfactant into DNA), surface tension results revealed that 
the CAC is dependent upon the alkyl tail length of the gemini surfactant but not on the structure 
of the spacer group (m-3-m vs. m-7-m vs. m-7NH-m). The 16-s-16 series of surfactants were 
always found to have a significantly smaller CAC in comparison to the 12-s-12 series, which is 
rationalized by the enhanced hydrophobic interactions in the 16-s-16/DNA complex. 
Complexation in the forward sequence was further evaluated using ITC, and the results obtained 
in our study were found to be in good agreement with those previously reported in the literature; 
that is, the enthalpy of binding between gemini surfactants and DNA is endothermic, and 
remains fairly constant until the reaction endpoint, where it drops abruptly to approximately 0 
kJ/mol. In contrast, in the reverse titration manner, a combination of ITC, particle size and zeta 
potential measurements revealed that the mechanism of complexation between gemini 
surfactants and DNA likely involves a complex series of linked equilibria, where the system 
progresses from a “beads on a string” type interaction to a complete reorganization and the 
formation of neutral complexes, followed by flocculation and precipitation. 
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 In chapter 2.2, the mixing interaction between gemini surfactants and DOPE was 
investigated using Clint’s, Rubingh’s and Motomura’s theories for mixed micelle formation. It 
was observed that the mixing interaction between the 16-3-16, 16-7-16 and 16-7NH-16 gemini 
surfactants and DOPE is antagonistic in nature, which is rationalized in terms of the differences 
in the preferred aggregate structures of these two components. The strength of the antagonistic 
interaction was found to be dependent upon the spacer group, where 16-3-16 experienced the 
strongest antagonistic interaction with DOPE, followed by 16-7NH-16 and then 16-7-16. 
Furthermore, the strength of the antagonistic interaction was found to be dependent upon the 
solution composition, where the magnitude of β was observed to decrease as the gemini 
surfactant molar fraction in solution was increased. Future studies in this investigation could 
potentially involve examining the effect of the gemini surfactant alkyl tail length on the 
interaction properties with DOPE; as well as using TEM images to examine how the structure of 
the gemini/DOPE aggregate evolves as the molar ratio of these components are varied. 
 Chapter 2 was concluded by evaluating the physical stability characteristics of gemini 
surfactant-based DNA delivery systems. The physical stability analysis was carried out in 
accordance to the FDA’s definition of the physical stability of liposome drug products, which is 
“a function of the integrity and size distribution of the lipid vesicles.” The membrane integrity 
characteristics of the gemini surfactant-based lipoplexes were evaluated using DNase sensitivity 
assays, while the particle size distribution characteristics were evaluated using DLS and by 
performing zeta potential measurements. Our results revealed that the physical stability of 
gemini surfactant-based lipoplexes is limited by their membrane integrity characteristics, which 
can potentially be attributed to the dissociation of the lipoplex structure as a result of the 
antagonistic mixing interaction experienced between the micelle-forming gemini surfactants and 
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DOPE. Future studies can potentially involve examining the stability characteristics of lipoplex 
systems formulated with gemini surfactants that a have a preference to form vesicular 
aggregates. This can potentially result in a more favourable mixing interaction between the 
gemini surfactant and DOPE, and ultimately a more stabilized gemini/DOPE aggregate. In 
addition, future studies should involve examining the transfection efficiency of the gemini 
lipoplex as a function of storage time.   
 The second objective of this thesis was to investigate the interactions between gemini and 
Tween surfactants. As discussed in chapter 3, an understanding of the interactions between 
gemini surfactants and other surfactants typically found in pharmaceutical formulations is 
essential when assessing the applications of gemini surfactants for use in pharmaceutical 
preparations. The results from this analysis demonstrated a general synergistic mixing behavior 
between the cationic gemini and the nonionic Tween surfactants, which was explained in terms 
of the decreased electrostatic repulsive forces between the headgroups due to the insertion of the 
Tween monomers between the cationic gemini monomers in the mixed micelle. The strength of 
synergism between the gemini and Tween surfactants was found to be dependent upon on the 
alkyl tail length of the Tween surfactant, where both the 18 carbon Tween 60 and Tween 80 
surfactants experienced a stronger synergistic interaction with 16-3-16, in comparison to the 12 
carbon Tween 20. As well, the saturation of the Tween alkyl tail was found to have an effect of 
the interaction with 16-3-16, where the Tween 60 (no unsaturations) was found to have a 
stronger synergistic with 16-3-16, in comparison to Tween 80 which has an unsaturation in its 
alkyl tail. Future studies can potentially look at examining the effect of the chemical structure of 
the gemini surfactant (i.e. spacer and alkyl tail length) on the interaction properties with the 
Tween family of surfactants. As well, this project could be expanded by evaluating the 
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interactions between gemini surfactants and a variety of other family of surfactants commonly 
found in pharmaceutical formulations; some examples include the sorbitan ester (Span) and 
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